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Abstract 
Conduction abnormalities affect prognosis in chronic heart failure (CHF). Previous 
investigators have observed abnormal delay in atrioventricular (AV) conduction in a 
rabbit model of left ventricular dysfunction (LVD) due to apical myocardial 
infarction. In this model, AV conduction time increased with increasing pacing rates, 
suggesting the most likely site of delay is the AV node. The mechanisms by which 
this occurs are not fully understood. The purpose of this thesis was to confirm that 
the abnormal prolongation of AV conduction time originates at the AV node in a 
rabbit model of LVD due to apical myocardial infarction, and explore possible 
mechanisms underlying the observation.  
Using surface electrogram recording and standardised pacing techniques in an 
isolated AV node tissue preparation I confirmed that there is abnormal prolongation 
of AV nodal conduction in this rabbit model of LVD, as evidenced by prolongation of 
atrio-hisian (AH) interval and Wenckebach cycle length (WCL) in LVD compared to 
control. Furthermore, using optical mapping of electrical activation using voltage 
sensitive dye I observed that the prolongation of the AH interval is predominantly a 
consequence of conduction delay between the inputs of the AV node and the 
compact nodal region. 
Neuro-hormonal derangement in chronic heart failure has a central role in the 
pathogenesis of the disease, with evidence of downregulation of beta (?)-
adrenoceptors in the left ventricular myocardium. I therefore explored the 
possibility of ß-adrenoceptor downregulation in the AV node as a mechanism 
underlying the abnormal AH interval prolongation in LVD. There was no evidence of 
ß-adrenoceptor downregulation in the AV node in LVD compared to control to 
account for the observed abnormal conduction delay.  
Adenosine is known to have profound effects on AV nodal conduction and the 
possibility of tonic excess of adenosine in LVD was explored as a possible mechanism 
for the prolonged conduction delay. Using an exogenously applied adenosine A1 
receptor antagonist there was no evidence of excess endogenous adenosine in LVD 
compared to control. There was, however, an increase in the sensitivity of the LVD 
samples compared to control to exogenous adenosine, with a significant increase in 
AH interval and WCL with increasing concentrations.  
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This thesis also investigates the effect of acidosis on AV nodal conduction. There 
was significant prolongation of the spontaneous sinus cycle length, AH interval and 
WCL, as well as the AV nodal functional and effective refractory periods, 
proportional to the degree of acidosis. These effects were reversible with return to 
normal pH. Optical mapping studies showed that the spatiotemporal pattern of AV 
nodal delay during acidosis was similar to that observed in LVD, with the 
predominant delay in conduction between the AV nodal inputs and the compact AV 
node.  
In summary this thesis has confirmed that even in the absence of a direct ischaemic 
insult to the AV junction, conduction abnormalities in the AV node may still occur as 
a pathophysiological response to a myocardial infarction resulting in LVD. The 
mechanisms underlying this response are likely to be complex and multiple, and are 
not yet clear. Establishing the electrophysiological basis and the effects of neuro-
hormonal modulators of atrioventricular nodal function may lead to development of 
targeted therapeutic strategies to improve overall survival and improve symptom 
control for patients with CHF.  
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Chapter 1 - Introduction 
Ashley M. Nisbet, 2008  Chapter 1; 26 
1 Introduction 
1.1  Clinical Context 
1.1.1 Conduction system abnormalities in chronic heart failure 
1.1.1.1 Survival and prognosis in chronic heart failure 
Chronic heart failure (CHF) is a significant cause of morbidity and mortality, with a 
10% annual mortality rate in newly diagnosed patients, and in established heart 
failure, 5-year survival rates of only 25% in men and 38% in women (1-3). A number 
of variables have been found to be predictors of prognosis, including New York 
Heart association (NYHA) class, peak oxygen consumption and total exercise time, 
left ventricular ejection fraction (LVEF), right ventricular ejection fraction (RVEF), 
pulmonary capillary wedge pressure, ventricular arrhythmias, levels of 
catecholamines, atrial peptides, plasma sodium, the presence of cachexia and 
conduction abnormalities (1;4). 
1.1.1.2 Electrocardiographic predictors of outcome in chronic heart failure 
ECG parameters are also associated with an adverse outcome in CHF. Figure 1-1 
illustrates how the various components of the surface ECG arise from the spread of 
activation and repolarisation throughout the heart. First or second-degree 
atrioventricular (AV) block has been shown to be an independent risk factor in 
idiopathic dilated cardiomyopathy, particularly in combination with either reduced 
LVEF or frequent ventricular couplets (5). Shamim et al (6) showed an increase in all 
cause mortality with progressive increase in the duration of the QRS complex. QRS 
duration was an independent variable on multivariate analysis, as were LVEF and 
peak oxygen consumption. Furthermore in 2002 this group demonstrated that the 
relative change in QRS duration over time was a more sensitive prognostic indicator 
than absolute values of QRS duration (7). This correlated with echocardiographic 
markers of deterioration of ventricular systolic function and increased LV filling 
pressures. The PR interval was also significantly longer in non-survivors than in 
survivors. Therefore, there is a close relationship between electrical and 
haemodynamic components of cardiac function and clinical outcome. 
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Figure 1-1- Origins of the ECG. The transmembrane AP for the SA node, the AV node, other parts 
of the heart’s conducting system, atrial muscle and ventricular muscle are illustrated with 
reference to the surface ECG. The ‘p’ wave corresponds to the depolarisation of the atrial 
myocytes. The QRS complex corresponds to the spread of activation across the ventricles. The 
ST segment occurs due to the electronegative summation of the ventricular AP plateaux, and the 
T wave results from the sequential repolarisation of the ventricular myocytes. (Adapted from (8)). 
 
1.1.2 Clinical significance of prolonged atrioventricular nodal delay 
Conduction delays are present in approximately 50% of patients with CHF (9). 
Atrioventricular and intraventricular conduction delay produce adverse 
haemodynamic effects by their impact on AV synchrony and left ventricular 
contraction/relaxation respectively. A long PR interval predisposes to pre-systolic 
mitral regurgitation (10). Multisite biventricular pacing techniques (also known as 
cardiac resynchronisation therapy (CRT)) improve cardiac function by synchronising 
ventricular contraction and relaxation (11-16). Further improvements in systolic 
function can be achieved by optimisation of preload by correct timing of AV delay 
(17-22). Breithardt et al (23) demonstrated that optimum cardiac index and Doppler 
indices of LV filling occurred at AV delays between 80 and 120ms in patients with 
NYHA Class III-IV CHF. Thus maximum improvement in LV performance requires both 
resynchronisation of AV conduction and optimisation of AV delay.  
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Figure 1-2– Percentage change in LV +dP/dt as a function 5 AV delays. Values shown for each 
pacing chamber (RV – right ventricle; LV – left ventricle; BV – biventricular). (Adapted from (24)).  
 
In a normal heart, atrial and ventricular systole are temporally coordinated allowing 
the efficient transfer of blood between the chambers and optimisation of cardiac 
output. Prolonged atrioventricular conduction in heart failure patients compromises 
ventricular filling, by reducing the atrial contribution to LV preload and due to pre-
systolic mitral regurgitation, resulting in a drop in the LV end diastolic pressure 
(LVEDP). In the Pacing Therapies for Congestive Heart Failure study (PATH-CHF), 
Auricchio et al (24) established that in addition to the improvement of contractile 
function due to the resynchronisation of inter/intraventricular contraction by 
biventricular pacing, AV delay is a significant determinant of changes in parameters 
of LV systolic function, as measured by LVEDP and LV dP/dtmax (Figure 1-2). A 
further subgroup analysis published in 2002 (25) confirmed that in the group of 
patients who responded to CRT, the maximum increases in pulse pressure were 
obtained at an AV delay that preserved the baseline values of LVEDP. This supports 
the hypothesis that preload is a significant determinant of the optimum acute 
haemodynamic impact of CRT. Overall, in comparison to standard medical therapy, 
CRT has been shown to reduce the combined end point of all cause mortality or first 
hospitalisation in patients with advanced heart failure (NYHA class III-IV) (Figure 1-
3) (12;26). Furthermore, a recent systematic review of trials of CRT in patients with 
Ashley M. Nisbet, 2008  Chapter 1; 29 
symptomatic heart failure has shown that when added to optimal medical therapy, 
CRT reduces both all cause mortality and heart failure hospitalisations by 
approximately 25% (27). 
 
Figure 1-3 – Kaplan-Meier estimates of the time to death or hospitalisation from worsening heart 
failure in control versus cardiac resynchronisation groups. The risk of an event was 40% lower in 
the resynchronisation group. (Adapted from (12)).  
 
1.2 The atrioventricular node 
“A riddle wrapped in a mystery inside an enigma” 
Winston Churchill, 1939 
Douglas P Zipes, 2000 
1.2.1 Historical perspective 
On a radio broadcast in 1939, Winston Churchill characterised Russia as “a riddle 
wrapped in a mystery inside an enigma”. This conclusion was also drawn by Douglas 
P Zipes in reference to our present understanding of the electrophysiology of the 
atrioventricular node (28). From the 19th to the early 20th century, the question 
“Why does the heart beat?” dominated cardiac research. The “myogenic versus 
neurogenic” debate had been ongoing for many years previously. In the second 
century, Claudius Galen observed “The heart, removed from the thorax, can be 
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seen to move for a considerable time, a definite indication that it does not need the 
nerves to perform its function” (29). The physiological debate over whether the 
heart beat was triggered by intrinsic excitation by the heart muscle itself or due to 
an external stimulus was ultimately decided by anatomists.  
In 1839, Purkinje discovered a network of grey, flat gelatinous fibres in the 
ventricular sub-endocardium of the sheep heart. He initially believed these fibres to 
be cartilaginous but then decided they were muscular (30). The true function of 
these conducting fibres was not realised until many years later.  
In 1893, Wilhelm His Jr, a Swiss born cardiologist and anatomist, discovered the 
bundle of specialised muscle fibres, which became known as the “Bundle of His”. 
This bundle was noted to be the only direct connection to conduct impulses 
between the atria and the ventricular muscle. In years thereafter his experiments 
confirmed that when the bundle was severed it caused “asynchronie in the beat of 
the auricle and ventricle” (31).  
In 1906, the monumental monograph of Sunao Tawara was published (32) . Through 
his work he described how he traced the Bundle of His back to find a compact node 
of fibres at the base of the inter-atrial septum, and forward where it connected 
with the fibres described by Purkinje years previously. He believed the conducting 
bundles were muscular tissue surrounded by connective tissue as opposed to nerve 
tissue, supporting the myogenic theory of the initiation and conduction of the heart 
beat (30;32).  
Finally, in 1907, Martin Flack and Arthur Keith discovered a structure at the sino-
auricular junction in the heart of a mole that histologically resembled the AV node. 
They recognised that this is where the dominating rhythm of the heart normally 
begins. It was named the sino-auricular (ultimately the sino-atrial) node (30). 
Cardiac research has now reached the centenary of the discovery of the sino-atrial 
and atrioventricular nodes. Despite many years of progress, the complex function of 
these structures, in particular the atrioventricular node, remains largely enigmatic 
and mysterious.  
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1.2.2 Anatomy of the atrioventricular junction 
1.2.2.1 Gross anatomy 
The atrioventricular node is the only normal electrical connection between the atria 
and the ventricles. The node lies in the lower atrial septum within the Triangle of 
Koch, bound superiorly by the tendon of Todaro, laterally by the orifice of the 
coronary sinus and inferiorly by the attachment of the septal leaflet of the tricuspid 
valve (Figure 1-4). The AV node has a mult ilayered structure. The most superficial 
layer is the transitional zone between fast conducting atrial muscle (A zone) and the 
region of the compact AV node (N zone). Action potentials from the transitional 
zone (AN cells) are similar in character to atrial action potentials. The mid-nodal 
region describes the “compact node” or nodal (N) zone, an area of slow conduction 
and slow action potential upstrokes (N-cells). The deepest layer is a transitional 
zone between the N zone and the His bundle and exhibits so called “NH (nodal-His)” 
action potentials (18;33-36). 
 
 
Figure 1-4 - The Triangle of Koch. IAS – inter-atrial septum; IVC – inferior vena cava; CrT – Crista 
terminalis; tT – tendon of Todaro; TrV – tricuspid valve; CS – coronary sinus; His – His bundle; 
AVNP – AV nodal input pathways.  
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1.2.2.2 Dual AV nodal pathways 
Anatomical and functional studies of the AV node have demonstrated the presence 
of two distinct input pathways, providing the substrate for clinically important AV 
nodal re-entrant tachy-arrhythmias. This was first demonstrated in dog (37), where 
the authors observed an “echo” (non-stimulated) ventricular beat elicited when 
they delivered an appropriately timed ventricular premature beat to the heart. 
Further studies in human subjects some years later demonstrated similar findings 
(38;39). The findings in dog and human studies have been confirmed in studies of 
the rabbit AV node (40-44). However, anatomical studies of humans with AV nodal 
re-entrant tachycardia or dual AV nodal pathways have shown that the AV node is 
structurally normal (45). Therefore dual AV nodal pathways are a functional rather 
than an anatomical problem, as demonstrated by Figure 1-5.  
 
Figure 1-5 – Dual AV nodal physiology. The atrium, AV node (AVN), and His bundle are shown 
schematically. The AV node is longitudinally dissociated into two pathways, slow and fast, with 
different functional properties. In each panel of this diagram, blue lines denote excitation in the 
AV node, which is manifest on the surface electrocardiogram, while black lines denote 
conduction, which is concealed and not apparent on the surface electroca rdiogram. A. During 
sinus rhythm (NSR) the impulse from the atrium conducts down both pathways. However, only 
conduction over the fast pathway is manifest on the surface ECG, producing a normal PR 
interval of 0.16 s. B. An atrial premature depolarization (APD) blocks in the fast pathway. The 
impulse conducts over the slow pathway to the His bundle and ventricles, producing a PR 
interval of 0.24 s. Because the impulse is premature, conduction over the slow pathway occurs 
more slowly than it would during sinus rhythm. C. A more premature atrial impulse blocks in the 
fast pathway, conducting with increased delay in the slow pathway, producing a PR interval of 
0.28 s. The impulse conducts retrogradely up the fast pathway producing a single atrial echo. 
Sustained reentry is prevented by subsequent block in the slow pathway. D. A still more 
premature atrial impulse blocks initially in the fast pathway, conducting over the slow pathway 
with increasing delay producing a PR interval of 0.36 s. Retrograde conduction occurs over the 
fast pathway and reentry occurs, producing a sustained tachycardia (SVT). (Adapted from 
http://rezidentiat.3x.ro/) 
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1.2.3 Cellular electrophysiology of the AV node 
Heterogeneity of ion channel and gap junction expression exists within the AV nodal 
architecture (46). Transitional cells of the AV node (AN and NH cells) have a 
relatively abundant sodium current (INa). There is a relative lack of expression of 
sodium channels in the ovoid type isolated cells (N cells), in which the main 
depolarising current is the L-type calcium current (ICa,L). This results in a relatively 
slow Phase 0 of the action potential and therefore a slow speed of conduction. In 
addition there is an inwardly directed Na-Ca exchanger current (INa,Ca). Also, at 
potentials relevant to the diastolic potential during spontaneous activity in the 
majority of cells a small time-independent inward current is present (If). Some N 
cells also exhibit the dihydropyridine sensitive sustained inward current (Ist). There 
is generally no Phase 1 in nodal cells, and there is usually a very brief plateau 
phase. The main repolarising currents of the AVN are the transient outward K+ 
current (Ito) and the delayed rectifier K+ current (IKr). Unlike atrial and ventricular 
myocytes, the cells of the sino-atrial and atrio-ventricular nodes do not have a 
stable resting potential. Following repolarisation, the membrane potential 
undergoes spontaneous depolarisation (phase 4 depolarisation or the pacemaker 
potential). The interactions between the background current (Ib) and the delayed 
rectifier current (IKr) plus the hyperpolarisation activated (or “pacemaker” current), 
contribute to the generation of the pacemaker potential, and consequently to the 
automaticity of the N cells (47;48). 
1.2.4 Specialised conduction characteristics of the intact AV node 
in response to rapid and premature stimulation 
AV nodal conduction delay is inversely proportional to the stimulating atrial 
prematurity. This fact has been determined by pacing protocols in which regular 
atrial pacing (S1) producing atrial activation (A1) are followed by a premature 
stimulus S2 producing a response (A2). AV nodal conduction delay is then measured 
as the interval between the atrial electrogram (A1 or A2) and the corresponding 
bundle of His spike (H1 or H2). Plotting A1A2 against A2H2 creates the AV nodal 
conduction curve. The specialised nature of conduction through the AV node is 
believed to be a consequence of the interaction of three factors, namely AV nodal 
recovery, fatigue and facilitation (49-52). Incomplete AV nodal recovery results in 
the generation of a longer A2H2 delay with a shorter A1A2 interval. The cellular 
response to a premature stimulus, S2, applied before full recovery, exhibits 
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decreased action potential amplitude and Vmax (dV/dt). This reduces the proximal 
conduction velocity and may explain the subsequent delay in the activation of the 
NH cells or the development of AV nodal block. AV nodal fatigue is the term used to 
describe the conduction delay when the atrium is paced continuously at a fast rate. 
Rate dependent activation failure (49) of the AV node is known as Wenckebach 
phenomenon (53). It may be related to the refractoriness of the least excitable 
element in the heterogeneous AV nodal conduction pathway. “Exhaustion” of the AV 
node has been postulated as a cause, and metabolic factors are thought to 
contribute (49;54;55). The clinical literature on AV nodal function uses the term 
‘decremental conduction’ to describe the increase in AH interval either in response 
to shortening S1S2 intervals, or to shortening of the basic S1S1 pacing interval. AV 
nodal facilitation describes the phenomenon that occurs following the premature 
atrial beat. For the same H2S3 interval (i.e. the recovery interval) the conduction 
delay becomes shorter with a shorter S1S2 interval.  
1.2.5 Rate dependency of the action potential duration and effective 
refractory periods in isolated AV nodal and atrial cells  
Rate-dependent periodicity has been demonstrated in single N cells isolated from 
the AV node as well as in intact node preparations (56-58). Isolated AV nodal cells 
beat spontaneously at between 180 and 260 beats per minute (bpm) (59). Repetitive 
stimulation of AV nodal cells at 300bpm results in a 1:1 response, but at rates of 
480bpm, a 2:1 response is observed. At 400bpm, a progressive reduction in the Vmax 
of successive APs is observed, with subsequent increasing latency. This results in 
failure of response to the 4th pulse and subsequent 3:2 response. This response is 
analogous to Wenckebach 2nd degree AV block in the intact heart. Atrial cells differ 
from AV nodal cells in that they sustain 1:1 activation even at pacing rates of 600 
bpm. The effective refractory period (ERP) of the intact AV node lengthens at 
higher rates. AV nodal cells show significant shortening of ERP at low rates, but 
Workman et al found no effect on the ERP at higher rates (58;59). However the 
exact region of the AV node from which the cells originated was not known and 
there is evidence of a differing contribution of different regions of the node to 
refractoriness. 
1.2.6 Factors affecting conduction velocity through the AV node 
Conduction through the AV node is relatively slow compared to conduction through 
the atria or ventricles, ensuring the sequential contraction of the atria followed by 
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the ventricles. The AV node serves a protective function during arrhythmias such as 
atrial fibrillation by limiting the number of impulses transmitted to the ventricles. 
In contrast, the AV node plays a key role in the maintenance of other arrhythmias; 
for example in supraventricular tachycardia the AV node is an integral part of the 
re-entrant conduction circuit. 
1.2.6.1 Ion channel conductance and membrane excitability 
There are a number of determinants of conduction velocity. At the cellular level, 
conduction velocity is affected by the excitability of the cell membrane, i.e. by a 
reduction in K+ conductance or by an increase in the current density of the 
depolarising current (Na+ or Ca2+) and by the degree of intercellular resistance (60).  
1.2.6.2 Gap junctional channels 
Gap junctional channels (connexins) play a prominent role in AV conduction. The 
mammalian heart contains three main isoforms of gap junctional protein, namely 
connexins Cx43, 40 and 45. There is heterogeneous expression of all three isoforms 
within the tissue of the Triangle of Koch. Cx43 has a major role in cell-cell 
communication between ventricular and atrial myocytes. It has relatively low 
expression within the N region of the AV node, but is expressed more in the 
transitional zones (the AN and NH regions). The posterior nodal extension has been 
shown to have the lowest Cx43 mRNA and the most abundant HCN4 mRNA expression 
in keeping with its low conduction velocity and pacemaker activity (61). Cx45 has 
been shown to be abundant in the compact node and both Cx40 and 45 in the NH 
region (44;62;63).  
1.2.6.3 Specific mutations in cardiac voltage gated ion channels 
Recently mutations in the cardiac voltage gated Na+ channel Nav1.5 (SCN5A) have 
been associated with familial cases of AV conduction disorders (64-67). Yoo et al 
(68) studied the expression of Na+ channel isoforms at the AV junction in rat and 
found that Nav1.5 expression was abundant in atrial and ventricular myocardium and 
left bundle branch, reduced in the inferior nodal extension and transitional zone, 
but absent in the compact node and penetrating bundle. In contrast, Greener et al 
(61) studied the expression of Nav1.5 mRNA in rabbit AV junction and found it to be 
abundant in the compact node and penetrating bundle, but absent in the posterior 
nodal extension and the transitional region immediately adjacent to this. Despite 
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these important species differences in the relative expression of Nav1.5 at the AV 
junction, mutations in or loss of this channel result in clinically important AV 
conduction disturbances and further research in human subjects is required to 
clarify the link.  
1.2.6.4 Tissue architecture 
Macroscopically the architecture of the myocardial tissue may also determine 
conduction velocity. In 2001, Kucera et al (69) studied microscopic impulse 
propagation using multiple optical recordings of transmembrane voltage in 
conjunction with patterned growth cultures of neonatal rat ventricular myocytes. 
They observed a 70% reduction in conduction velocity by reducing excitability, but a 
99% reduction by reducing electrical coupling (in the absence of structural 
discontinuities). Furthermore, they observed slowing of conduction velocities 
evoked by branching tissue geometries in the absence of electrical uncoupling. The 
conduction velocities observed in the latter were similar to those observed in the AV 
node. Histological sections of the AV node have demonstrated a highly complex 
tissue architecture consisting of numerous intermingled strands separated by 
connective tissue, and this may correlate with the prototype tissue structures used 
in the above cited study. Furthermore, in studies of aged hearts, microfibrosis was 
found to result in a reduction in transverse conduction velocity in atrial and AV 
nodal tissues (70).  
1.2.7 Autonomic modulation of AV nodal conduction 
The AVN is richly innervated by the sympathetic and parasympathetic branches of 
the autonomic nervous system. There is reciprocal action of the two divisions of the 
autonomic nervous system, having different effects on the chronotropic, 
dromotropic and inotropic responses of the heart.  
1.2.7.1 Sympathetic innervation 
Acetylcholine (ACh) is the predominant sympathetic preganglionic neurotransmitter; 
norepinephrine (NE) is the predominant post-ganglionic neurotransmitter. The 
arrival of an impulse at the nerve terminal in the AVN effects NE release, and this 
interacts with ?-adrenergic receptors on the cardiac effector cell membrane. 
Increases in sympathetic activity raise intracellular levels of cyclic adenosine mono-
phosphate (cAMP). This sets off a cascade of intracellular events culminating in 
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changes in the conductivity of ion channels within AV nodal conduction fibres. At 
rest, cardiac sympathetic activity occurs in rhythmic bursts synchronous with 
respiration. However, changes in heart rate and AV nodal conduction velocity do not 
follow the same pattern. The responses are slow, as are the recoveries of the 
responses to their basal level as a result of the slow removal and re-uptake of NE 
from the cardiac effector cell receptor and into the presynaptic nerve terminals 
respectively. AV conduction time depends on the interaction between the prevailing 
heart rate and the level of sympathetic tone, both of which exert opposite effects 
on AV conduction. If the heart rate is held constant by artificial pacing, sympathetic 
stimulation decreases AV conduction time. However, an increase in heart rate by 
atrial pacing prolongs AV conduction time.  
1.2.7.2 Parasympathetic innervation 
The vagus nerve carries the efferent parasympathetic fibres to the heart. ACh is the 
predominant neurotransmitter released from both pre- and post-ganglionic vagus 
nerve terminals. The right vagus nerve has a much greater effect on AV conduction 
than the left. Vagal stimulation leads to reduction in the conduction velocity and 
prolongation of the refractory period of the AVN by hyperpolarisation of the AVN 
cell membrane and reduction of the amplitude and the upstroke velocity of the 
cardiac action potential (51;71). This results in prolongation of the AH interval by 
blocking conduction at the mid-nodal (N) and NH regions of the AVN. When the 
heart rate is held constant by atrial pacing vagal stimulation always prolongs the AV 
conduction time.  
1.2.7.3 Other neural modulators of AV nodal function 
Adenosine is ubiquitous as it is involved in the metabolism and catabolism of 
adenosine tri-phosphate (ATP). ATP is packaged and co-released with ACh and NE, 
and serves as a source of adenosine to bind to cell membrane receptors and affect 
intracellular processes. Adenosine may signal conditions that are detrimental to the 
organism such as hypoxia. In hypoxia, adenosine reduces the myocardial oxygen 
demand by reducing sinus node automaticity and AV node conduction velocity. 
Furthermore, adenosine reduces AV nodal excitability by inactivation of ICa,L and 
activation of a time-dependent inwardly rectifying potassium current. The effects of 
adenosine may counteract the effects of ?-adrenergic stimulation by inhibiting the 
activation of adenylyl cyclase. The renin-angiotensin system, via angiotensin II, has 
been implicated in the control of heart rate. Angiotensin II has a positive 
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chronotropic effect when infused directly into the sinus node via the cannulated 
sinus node artery in the isolated canine heart (72). Moreover, Bastien et al (73) 
observed an abundance of angiotensin II receptors of subtype AT2 in the conducting 
system of the neonatal and adult rat heart. The role of angiotensin II in the 
regulation of AV nodal conduction remains to be elucidated.  
1.2.7.4 The autonomic nervous system in chronic heart failure 
In chronic heart failure, excess norepinephrine levels lead to downregulation and 
desensitisation of myocardial ?-adrenoceptors. ? -1-adrenoceptors (the site of action 
of NE) are preferentially down-regulated in heart failure. This occurs through a 
combination of inhibition of receptor signalling pathways, upregulation of inhibitory 
G-proteins, and a reduction in adenylate cyclase and cAMP levels. All of these 
effects result in a reduction in contractility in ventricle (74-76). The negative 
inotropic effect of chronic catecholamine excess and subsequent ?-adrenoceptor 
downregulation has been demonstrated in rabbit models using chronic isoprenaline 
infusion via the implantation of an osmotic minipump (77;78). Furthermore, 
previous work in our laboratory has demonstrated evidence of reduced ?-
adrenoceptor sensitivity to the inotropic effects of isoprenaline in papillary muscles 
from rabbits with LVD compared with sham operated controls (79). 
1.3 The rabbit model of myocardial infarction 
1.3.1.1 Pathophysiology of myocardial infarction 
Myocardial infarction is the result of prolonged regional myocardial hypoperfusion 
resulting in tissue necrosis. A trans-mural infarct is produced as a result of abrupt, 
complete cessation of perfusion of sufficient duration to cause irreversible cell 
death. The infarct related artery determines the region of infarction, and the 
extent of necrosis is influenced by the presence or absence of previous ischaemia in 
that territory. Prior ischaemia may protect the tissue from further ischaemic insult 
through the development of collaterals. The most obvious structural change that 
occurs following a myocardial infarction is development of a fibrous scar in the 
infarct territory. Non-infarcted tissue also undergoes a process of remodelling. 
There is gradual hypertrophy of the non-infarcted ventricular myocytes as they 
adapt to the increased workload. This effect may be pro-arrhythmic (1;80).  
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1.3.1.2 Choice of animal model for this study 
A well-characterised model of myocardial infarction (MI) induced by coronary artery 
ligation was used in this study. The marginal branch of the left circumflex coronary 
artery, which supplies most of the left ventricular free wall, was ligated halfway 
between the atrioventricular groove and the cardiac apex to produce an ischaemic 
area of 30-40% of the left ventricle. As there is relatively little collateral circulation 
in the rabbit, a homogenous apical infarct was produced occupying on average 14% 
of the total endocardial and epicardial surfaces towards the apex of the left 
ventricle. Many studies have previously used a canine model of infarction but the 
canine coronary circulation is different from human in that the epicardium is 
protected by a better developed collateral circulation. Thus the canine model does 
not necessarily reflect the infarct process that occurs in human hearts. In rabbit, 
the ligation of the marginal branch of the left circumflex coronary artery results in a 
trans-mural antero-apical myocardial infarction with associated left ventricular 
systolic dysfunction and electrophysiological dysfunction (as demonstrated by the 
increase in frequency of ventricular fibrillation compared to sham operated hearts). 
This model is thought to be consistent with acute MI in humans without prior 
ischaemia in the infarct related territory.  
1.3.1.3 Evidence of altered atrioventricular nodal conduction in the rabbit 
model of heart failure 
The prognosis in chronic heart failure is affected by conduction abnormalities 
affecting both the AV node and the His-Purkinje system (5-7;9;17). The mechanisms 
by which this occurs are not fully understood. Previous work from this laboratory 
has demonstrated delay in AV conduction in this rabbit model of left ventricular 
dysfunction (LVD)/heart failure due to MI (81). In this model as described above the 
infarct is localised to the left ventricular apex and there is no direct ischaemic 
insult to the basal myocardium. Using optical mapping, a mean increase of 20ms 
(20%) was found in the interval between right atrial stimulation and left ventricular 
epicardial activation in LVD hearts compared with controls. There was no decrease 
in left ventricular transmural or epicardial conduction velocity. The AV conduction 
delay increased with increasing pacing rates, suggesting that the site of increased 
delay was most likely to be the atrio-ventricular node. Initial histological analysis 
failed to demonstrate any change in the tissue architecture of the AV node to 
account for this. This suggests that in addition to structural re-modelling of non-
infarcted ventricular myocytes, there may be electrophysiological re-modelling 
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affecting the conducting system, in particular the AV node, in this rabbit model of 
LVD due to MI. 
1.4 Aims and hypothesis 
The aims of this thesis were: 
1. To confirm that abnormal prolongation of atrioventricular conduction time 
originates at the atrioventricular node in the rabbit model of heart failure; 
2. To investigate the spatiotemporal pattern of this electrical slowing using optical 
mapping; 
3. To examine in-vivo markers of AV delay in rabbit and identify any changes 
consistent with prolonged AV nodal conduction time in the rabbit model of heart 
failure; 
4. To explore the mechanisms underlying any observed prolongation of AV nodal 
delay, and  
5. To study AV nodal conduction characteristics in other clinically relevant 
conditions, namely acidosis and aging. 
The hypothesis at the outset of this thesis was that chronic heart failure in the 
rabbit results in an increase in AV conduction time at the level of the AVN, and that 
the increased AV conduction time is a consequence of ?-adrenoceptor 
downregulation  
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Chapter 2 – General Methods 
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2 General methods 
2.1 Rabbit model of left ventricular dysfunction due to 
apical myocardial infarction 
A well-characterised model of myocardial infarction (MI) induced by coronary artery 
ligation was used in this study (82-88). Procedures were undertaken in accordance 
with the United Kingdom Animals (Scientific Procedures) Act 1986 and conform to 
the Guide for the Care and Use of Laboratory Animals published by the US National 
Institutes of Health (NIH Publication No. 85-23, revised 1985). Adult male New 
Zealand White rabbits (2.5-3.0kg) were given premedication with 0.4ml/kg 
intramuscular Hypnorm [fentanyl citrate (0.315mg/ml): fluanisone (10mg/ml), 
Janssen Pharmaceuticals]. Anaesthesia was induced with 0.25-0.5mg/kg midazolam 
(Hypnovel, Roche) given via an indwelling cannula in the marginal ear vein. The 
rabbit was intubated and ventilated using a Harvard small animal ventilator with a 
1:1 mixture of nitrous oxide and oxygen containing 1% halothane at a tidal volume 
of 50 ml and a frequency of 40 per minute. Preoperative antibiotic prophylaxis was 
given with 1 ml Amfipen (ampicillin 100 mg/ml, Mycofarm UK Ltd) intramuscularly. 
A left thoracotomy was performed through the 4th intercostal space. Quinidine 
hydrochloride 10mg/kg (Sigma Pharmaceuticals) was administered intravenously 
prior to coronary artery ligation to reduce the incidence of ventricular fibrillation. 
The marginal branch of the left circumflex coronary artery, which supplies most of  
the left ventricular free wall, was ligated halfway between the atrioventricular 
groove and the cardiac apex to produce an ischaemic area of 30-40% of the left 
ventricle. As there is relatively little collateral circulation in the rabbit, a 
homogenous apical infarct was produced occupying on average 14% of the total 
endocardial and epicardial surfaces towards the apex of the left ventricle (Figure 2-
1A)(89). 
Ventricular fibrillation occurred in approximately 30% of cases; usually 8 to 12 min 
following occlusion, and defibrillation was undertaken with a 5-10J epicardial DC 
shock. Once the animal was stable, the thoracotomy was closed. The animals were 
then given 20ml of isotonic saline intravenously to replace perioperative fluid losses 
and allowed to convalesce in a warm clean environment with adequate monitoring 
for any early signs of distress. Analgesia was given with 0.04mg/kg intramuscular 
Vetergesic (buprenorphine hydrochloride 0.3mg/ml, Reckitt & Colman Products Ltd) 
immediately after surgery and the next morning.  
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Sham-operated animals underwent thoracotomy with the heart manipulated in a 
similar fashion except that the artery was not tied. 
2.2 Characteristics of the rabbit model of myocardial 
infarction 
Echocardiography was performed 1 week prior to sacrifice to assess in-vivo cardiac 
function, using a 5 MHz paediatric probe with a Toshiba sonograph (Sonolayer 100). 
The rabbit was sedated with 0.3 mg/kg Hypnorm and a small area of the anterior 
chest wall was shaved to allow a satisfactory echo window. The coronary ligated 
animals (MI) showed significant haemodynamic dysfunction in terms of increased 
left ventricular end-diastolic dimension (LVEDD), left atrial dimension (LAD) and 
decreased ejection fraction (90). Evidence of congestion was manifest in significant 
increases in lung and liver wet weight present at post-mortem examination. 
Previous work has shown that this animal model shows significant cardiac 
hypertrophy, evident as a 20-30% increase in heart wet weight, left ventricular dry 
weight (see Table 2-1) (91;92) and increased cardiomyocyte length (93). In vivo 
haemodynamic measurements reveal a normal cardiac output but raised end 
diastolic pressure and reduced response to an increased pre-load in this model 
(92;93).  Increased inducibility of arrhythmias and lowered fibrillation threshold 
observed in vitro (89;93) suggesting accompanying electrophysiological dysfunction. 
The infarct model is associated with a significant late mortality as demonstrated by 
the Kaplan-Meier graph in Figure 2-1B. 
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 INFARCT (n = 25) SHAM (n= 21) p value 
Body weight (kg) 3.60 ± 0.05 3.56 ± 0.07 NS 
Ejection fraction (%) 42.6 ± 1.3 71.2 ± 1.4 <0.001 
LAD (mm) 15.8 ± 0.3 10.9 ± 0.3 <0.001 
LVEDD (mm) 20.0 ± 0.3 16.8 ± 0.3 <0.001 
Liver weight (g) 93.0 ± 2.4 81.0 ± 4.0 <0.02 
Lung weight (g) 13.1 ± 0.8 10.9 ± 0.3 <0.01 
Heart weight (g) 13.1 ± 0.4 11.3 ± 0.4 <0.005 
LV dry weight (g) 1.40 ± 0.06 1.15 ± 0.04 <0.002 
RV dry weight (g) 0.57 ± 0.05 0.39 ± 0.02 <0.005 
Table 2-1- Characteristics of the rabbit model of LVD (From (90) ). Results expressed as mean ± 
SEM. 
 
 
Figure 2-1 – A – schematic diagram of the infarct model. B – Kaplan-Meier survival curve of sham 
versus MI, demonstrating increased mortality associated with coronary ligation (from (94)) .  
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2.3 In vivo electrocardiogram recordings 
In-vivo analysis of the electrocardiogram was carried out to allow determination of 
RR and PR intervals and QRS duration in the intact animal, and to identify any effect 
of LVD on these parameters. Recordings were taken immediately after 
echocardiography therefore no additional sedation or anaesthesia was required. 
Three electrodes were positioned subcutaneously and the electrocardiogram 
recorded from lead II.  
2.3.1 Analysis of in-vivo electrocardiograms 
The ECG data were acquired using a MP100A data acquisition unit (Biopac Systems 
Inc, Santa Barbara, California) which converted the ECG signals to digital format. 
Signals were recorded using software associated with the MP100 system, 
AcqKnowledge (version 3.5.3, Biopac Systems Inc, Santa Barbara, California). Data 
files were then viewed using locally developed software (ECG Explore, Dr FL Burton, 
University of Glasgow) which allowed conversion to text files, which could be 
imported into the ECG analysis program. Analysis of the RR and PR intervals and the 
QRS duration was carried out using commercially available software (Chart, version 
5, ADInstruments). A representative sample of 1000 beats at steady state (as 
determined by the lack of significant variation in the RR interval (less than 10ms) 
over the recording period) were selected from each experimental condition. From 
this, the mean RR interval, mean PR interval and mean QRS duration were 
determined. Comparisons were made between the sham and ligated animals. To 
identify the presence of a correlation, the PR interval versus the RR interval was 
also plotted for each condition, as was the PR interval versus the QRS duration.  
2.4 The isolated atrioventricular node 
2.4.1 Tissue preparation 
Under terminal anaesthesia with sodium pentobarbitone 200mg/kg (Rhone Merieux) 
mixed with 500IU of heparin, hearts from adult male New Zealand White rabbits 
were rapidly excised and placed in ice cold Tyrode’s solution, of the following 
composition (mmol/L): Na+ 134.5, Mg2+ 1.0, K+ 5.0, Ca2+ 1.9, Cl- 101.8, SO4 1.0, 
H2PO4 0.7, HCO3 20, acetate 20 and glucose 50. The pH of the solution was 
maintained at 7.4 by continuous bubbling with mixed gas of 95% oxygen and 5% 
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carbon dioxide. The isolated AV node preparation was created by the removal of all 
ventricular tissue, followed by an incision around the crest of the right atrial 
appendage, which when folded open exposed the endocardial surface of the right 
atrium and inter-atrial septum. Remaining left atrial tissue was removed, leaving a 
section of tissue containing the triangle of Koch, the Crista Terminalis, the right 
atrial appendage and a small section of right ventricle and inter-ventricular septum 
(Figure 2-2). The sinus node was left intact. This tissue was pinned onto a Sylgard 
plate and superfused with oxygenated Tyrode’s solution. A constant superfusion rate 
of 40ml/min was maintained using a Gilson Minipuls 3 peristaltic pump. 
Temperature was maintained at 37ºC. Figure 2-3 illustrates the isolated 
atrioventricular node superfusion system. 
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Figure 2-2 – Dissection of the isolated AV node preparation. A. The ventricles are removed via an 
incision distal to the AV groove (1). Then an incision around the crest of the right atrial 
appendage (2) allows exposure of the endocardial surface of the interatrial septum. B. With the 
ventricles removed, the triangle of Koch can be identified and the remaining left atrium and 
ventricular tissue can be removed safely. C. The isolated AV node pinned out on Sylgard, 
demonstrating the structures of the triangle of Koch and the position of the stimulus and His and 
atrial electrodes. (CrT: crista terminalis (atrial electrode position), IVC: inferior vena cava, CS: 
coronary sinus, tT: tendon of Todaro, FO: fossa ovalis, TrV: tricuspid valve, His: His bundle 
electrode position, *: AV node region. 
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Figure 2-3 – Isolated AV node superfusion appara tus 
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2.4.2 Surface electrogram recording and pacing protocols 
A bipolar silver wire stimulating electrode was positioned on the endocardium at the 
right atrial appendage near the sinus node. The atrium was driven by a Digitimer 
DS2 stimulator that provided twice threshold 2ms wide rectangular voltage pulses. 
Timing of the pulse was computer controlled using locally developed software (Dr FL 
Burton, University of Glasgow).  
Two silver wire bipolar extracellular recording electrodes were developed to allow 
surface electrograms from the low inter-atrial septum and the His bundle region to 
be acquired. The distance between each pair of bipolar electrodes was 14mm. Atrial 
and His bundle electrodes were positioned on the endocardial surface using a 
Narishige micromanipulator. Effort was made to ensure consistent distance between 
the electrodes to ensure the conduction times were not affected by heart size. The 
electrodes were connected to a monophasic action potential (MAP) amplifier 
(custom built by Dr Mark Watts, Glasgow Royal Infirmary). Electrograms underwent 
high pass (40Hz) filtering within the MAP amplifier, which was connected to an 
oscilloscope (Nicolet Instruments Corporation, Wisconsin, USA) to allow real-time 
viewing of the electrograms. 
2.4.3 Analysis of surface electrograms from the isolated 
atrioventricular node 
The rate dependent properties of the AV node are determined by standard pacing 
protocols. Electrograms recorded from the surface of the isolated AV node 
preparation were recorded using locally developed ECG acquisition software (NMap, 
Dr FL Burton, University of Glasgow). The basic stimulus cycle length was 300ms or 
10% shorter than the spontaneous sinus cycle length. The standard basic stimulus 
protocol (in which sixteen basic beats were followed by a one second pause, with 
the cycle length decrementing by 5ms intervals after each pause) allowed atrio-
Hisian (AH) intervals and Wenckebach cycle length to be derived. Examples of the 
signals acquired and the analysis methods are outlined in Figure 2-4.  
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Figure 2-4 – A – Pacing method to derive AH intervals and Wenckebach cycle length at basic 
pacing cycle length (S1S1 (ms)). B – Surface electrograms derived from the isolated AV node 
preparation at pacing cycle length S1S1 300ms (thus A1A1 interval = 300ms). C- Progressive 
prolongation of the AH interval (x=35ms; y=39ms; z=45ms). Rate dependent activation failure of 
the His bundle occurs at PCL 100ms, i.e. 100ms is the Wenckebach cycle length. 
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The functional and effective refractory periods of the AV node and the atrial 
effective refractory periods were derived by a premature stimulation protocol.  The 
AV nodal effective refractory period (ERP) is defined as the longest A1A2 interval 
that fails to elicit an H2 response. The AV nodal functional refractory period (FRP) is 
defined as the shortest H1H2 interval achieved by premature stimulation The atrial 
effective refractory period is defined as the longest S1S2 interval that fails to elicit 
an A2 response. This protocol consisted of sixteen basic beats followed by one 
premature beat followed by a one second pause (Figure 2-5A). The premature beat 
coupling interval was decremented by 5ms steps until atrial refractoriness (defined 
as the longest S1S2 interval that failed to elicit an A2 response) occurred. These 
protocols allow consistent and reproducible creation of AV nodal conduction and 
refractory curves (Figure 2-5B and 2-5C), from which parameters of AV nodal 
function can be derived. In addition, the spontaneous sinus cycle length was 
recorded in every experiment.  
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Figure 2-5 – A – Pacing method to derive functional and effective refractory periods of the AV 
node showing introduction of a premature stimulus after a 16 beat basic drive train at S1S1 
300ms. B – Surface electrograms derived from the isolated AV node showing blocked 
conduction to the His bundle at S1S2 110ms. C – By plotting the A2H2 interval against the A1A2 
interval, the AV node conduction curve is created (red). By plotting the H1H2 interval against the 
A1A2 interval, the AV node refractory curve is created (blue) and the FRP and ERP can be 
determined.  
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2.5 Optical mapping of the atrioventricular node 
2.5.1 Principles of optical mapping using fluorescent voltage 
sensitive dyes 
The AV node is an entity of incredible structural and functional complexity (46). The 
technical challenges of attempting to impale multiple glass microelectrodes into 
this small region are such that it is difficult to use this technique to characterise, 
with accuracy, the spread of activation across the inputs and output of the compact 
nodal region. Imaging of transmembrane potentials using voltage sensitive 
fluorescent dyes has become a major tool for the study of electrical activation in 
myocardial tissue. Recent progress in this imaging modality has allowed the study of 
activation patterns in the AV node, helping to link its functional complexities to its 
anatomic structure (95-99).  
An optical mapping system consists of three main components (Figure 2-6): 
1. The heart preparation, stained with a fluorescent voltage sensitive dye; 
2. A system of optics, which filters the fluoresced light emitted from the heart 
preparation, then focuses it on to a photo-detector, and; 
3. A photo-detector, which quantifies the emitted light from the preparation.  
Optical mapping allows the simultaneous recording of the electrical activity of 
hundreds to tens of thousands of sites on a cardiac surface (For review see 
(100;101)). Hearts are first loaded with a voltage-sensitive fluorescent dye (such as 
RH237) that binds to the myocyte membrane with high affinity. The general 
principle underlying optical mapping is that photons of an appropriate excitation 
wavelength are absorbed by the voltage-sensitive dye. The dye forms an unstable 
state, from which it falls back to its baseline state, emitting photons of a longer 
wavelength. The key property of voltage sensitive dyes is that the emission 
spectrum of the dye is voltage dependent. In summary, after being excited by short 
wavelength light, the dye fluoresces at a longer wavelength (Stokes Law). The 
spectral characteristics of this fluorescence are altered by the membrane potential 
of the preparation. Figure 2-7 illustrates how membrane depolarisation results in a 
shift of RH237’s fluorescence spectrum to shorter wavelengths. This spectral shift 
affects the amplitude of the fluorescence as measured beyond a fixed long 
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wavelength cut-off. Therefore membrane depolarisation results in a relative fall in 
fluorescence at longer wavelengths. On membrane repolarisation, the spectrum 
returns to its original characteristics, resulting in an increase in fluorescence back 
to pre-activation levels. 
 
Figure 2-6 - – Schematic diagram of the AV node optical mapping apparatus  
 
The nature of the optical action potential (AP) is different from the transmembrane 
AP recorded by a microelectrode. For this reason, the optical AP upslope is slower 
than the simultaneous transmembrane AP. Cells adjacent to each other activate in 
rapid succession as the wave of excitation spreads. The extent of upstroke slowing 
depends on the number of cells influencing the membrane potential recording. In 
optical mapping the extent of slowing of the upstroke of the optical AP is 
determined by the spatial resolution of the optical system. The spatial resolution is 
determined by a combination of the optical magnification, and the number of 
recording sites on the detector. The optical magnification is a limiting factor on the 
spatial resolution as increasing magnification lowers the signal to noise ratio.  
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Previously it was thought, that similar to contact electrodes, optical recordings 
originated from only the very surface layer of the epi/endocardium. Evidence now 
shows that optical measurements may penetrate deeper. Using a transparent 
mapping array, Knisley et al. compared simultaneously the excitation intervals of 
optical and extracellular electrical recordings, and demonstrated that the 
differences between them could be attributed to deeper optical interrogation and 
the accompanying fibre rotation (102). This ‘depth of field’ effect is an additional 
complication, but its dependency on the optical properties of the set-up allows it to 
be quantified using the standard optical equation.(103):  
Depth of Field = 1000?m/[(7 × NA × magnification) + ?ex/2(NA)2 
(where NA is the numerical aperture of the collecting lens and ? ex  is the wavelength 
of the emitted light). 
Movement during myocardial contraction alters the site that the detector is focused 
on, and therefore changes the signal fluorescence for reasons unrelated to the 
membrane potential (movement artefact). Although electro-mechanical uncoupling 
agents can be used to reduce or even eliminate movement, evidence is growing that 
they alter the electrophysiological properties that are being studied (104-107). 
Motion artefact while imaging the AV junction was minimal as this area is largely 
composed of fibrous non-contractile myocardium therefore the use of an excitation-
contraction un-coupler was not necessary  
 
Figure 2-7.- Diagram of voltage -sensitive spectral shift. Depolarisation produces a reduction in 
fluorescence at the red end of the spectrum e.g. RH237. (Adapted from (108)). 
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2.5.2 Langendorff perfusion 
Under terminal anaesthesia with sodium pentobarbitone 200mg/kg (Rhone Merieux) 
mixed with 500IU of heparin, hearts from adult male New Zealand White rabbits 
were rapidly excised and placed in ice cold Tyrode’s solution, of the following 
composition (mmol/L): Na+ 134.5, Mg2+ 1.0, K+ 5.0, Ca2+ 1.9, Cl- 101.8, SO4 1.0, 
H2PO4 0.7, HCO3 20, acetate 20 and glucose 50. The pH of the solution was 
maintained at 7.4 by continuous bubbling with mixed gas of 95% oxygen and 5% 
carbon dioxide. The solution was filtered through a 5µm filter (Whatman). The heart 
was mounted on the aortic cannula for Langendorff perfusion. The temperature was 
maintained at 37°C. A constant perfusion rate of 40ml/minute was maintained using 
a Gilson Minipuls 3 peristaltic pump. Perfusion pressure was monitored with a 
transducer in series with the aortic cannula. While undergoing Langendorff 
perfusion, hearts were loaded with a 200µl bolus of the voltage sensitive dye RH237 
(Molecular Probes) dissolved in DMSO (1mg/ml) administered by slow injection into 
the coronary circulation via an injection port in the bubble trap. The fractional 
fluorescence change caused by an action potential has previously been shown to be 
in the range 2 to 6% at 514.5 nm excitation (109). In preliminary experiments, in 
keeping with previous work undertaken by other groups (43;95;97), the voltage 
sensitive dye di-4-ANEPPS was used. However I found superior signal amplitudes and 
signal to noise ratios using RH237 and therefore used this consistently throughout 
the remainder of the study. Hearts were then removed from the Langendorff 
cannula and returned to ice-cold Tyrode’s solution to induce cardioplegia before 
dissection of the isolated AV node preparation as described above. 
2.5.3 Optical imaging of AV nodal conduction 
A schematic diagram of the optical mapping apparatus is shown in Figure 2-6. The 
isolated AV node preparation was dissected as described above and mounted onto a 
Sylgard base within a custom made imaging chamber, designed to allow superfusion 
of the AV node preparation and simultaneous programmed stimulation, recording of 
surface electrograms from the atrial and His bundle regions as well as imaging of 
patterns of activation from optically derived action potentials. The preparation was 
superfused with oxygenated Tyrode’s solution at a rate of 40ml/min maintained by 
a Gilson Minipuls 3 peristaltic pump. The temperature was maintained at 37°C. 
Light emitted from four 75W tungsten-halogen bulbs was passed through short-pass 
(535±50nm) filters and directed onto the endocardial surface of the AV node 
preparation. Light emitted from the tissue was collected by the camera lens (Nikon 
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50mm) and focused onto the charged coupled device (CCD) array (Dalsa, Canada) via 
a 695nm high-pass filter. This system affords flexibility in the choice of mapping 
area and spatial resolution (80x80, 40x40 or 26x26 pixels), traded off against 
maximum temporal resolution (1kHz, 3kHz & 5kHz respectively) and signal-to-noise 
ratio. Recordings of up to 5 seconds (limited by RAM) were saved to computer disk 
for later analysis. The image of the AV node region was focused onto the array such 
that an area of 14.5x14.5mm2 at a spatial resolution of 40x40 pixels (3kHz) was 
imaged. This was found to be optimum for imaging AV nodal activation, allowing 
mapping of AV nodal inputs and output to the His bundle, as identified by the 
surface electrograms. 
2.5.4 Analysis of optically derived action potentials from the 
isolated AV node preparation. 
Analysis of optically derived action potentials (AP) from the isolated AV node 
preparation was carried out on locally developed software (“Optiq”, Dr Francis 
Burton, University of Glasgow). Surface electrograms recorded during optical 
mapping experiments could be concurrently visualised and analysed using this 
program. This in addition to the integrated functionality allowing direct import of 
the CCD image from each experiment allowed accurate anatomical and functional 
characterisation of optical signals. 
 
 
Figure 2-8 – Photograph of isolated AV node preparation in optical imaging chamber. 
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A bipolar silver wire stimulating electrode was positioned on the endocardium at the 
right atrial appendage near the sinus node. The atrium was driven by a Digitimer 
DS2 stimulator that provided twice threshold 2ms wide rectangular voltage pulses. 
Timing of the pulse was computer controlled using locally developed software (Dr FL 
Burton, University of Glasgow). Surface electrograms were recorded using a pair of 
bipolar silver electrodes positioned at the Crista terminalis (for the atrial 
electrogram) and at the central fibrous body (for the His bundle electrogram). The 
distance between the electrodes remained consistent throughout each experiment 
due to fixed holes in the imaging chamber front plate (Figure 2-8). Adjustment of 
the position of the front plate allowed fine adjustment of electrode position without 
altering the inter-electrode distance. The electrodes were connected to a MAP 
amplifier (custom built by Dr Mark Watts, Glasgow Royal Infirmary). Electrograms 
underwent high pass (40Hz) filtering within the MAP amplifier, which was connected 
to an oscilloscope (Nicolet Instruments Corporation, Wisconsin, USA) to allow real-
time viewing of the electrograms. Furthermore, electrograms were recorded and 
digitised by the Redshirt imaging system and could be visualised and analysed 
simultaneously with the optically derived signals. There was no evidence of 
alteration of the AV nodal conduction time with the addition of voltage sensitive 
dye, as illustrated by Figure 2-9. At PCL 250ms there was no significant change in 
the AH interval over an 80 minute period regardless of fluorescence and in spite of 
the addition of a further bolus of RH237 to improve fluorescence signals.  
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Figure 2-9 – Association of fluorescence over time versus AH interval with RH237 (at baseline 
200µl RH237 injected via Langendorff followed by a further bolus of 400µl added to the effluent 
for re-circulation).  
Optically derived action potentials result from fluorescent signals emitted from a 
group of cells within the three dimensional volume of myocardium aligned with the 
photodiode. The image of the AV node was magnified such that each pixel 
represented signals derived from a 0.36x0.36mm area of endocardium. The depth of 
field of the collecting lens restricted the fluorescence measurements to a layer of 
cells up to 500µm from the surface.  
Three measures of activation derived from optical signals were studied, each 
analysed relative to the onset of the atrial electrogram: 
?? Tact (activation time). Tact was defined as the time point of the maximum 
rate of rise of the AP upstroke (dF/dtmax), defined as the first derivative of 
the fluorescence signal. 
?? Tpeak (time to peak of the AP). Tpeak was defined as the time in milliseconds 
from the defined start point (the first peak of the atrial electrogram) to the 
peak amplitude of the AP.  
?? TactM . TactM was defined as the activation time point midway between the 
baseline and the peak of the AP. 
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The mean ± SEM of each parameter defined above was determined in 4 distinct 
regions of the preparation, consisting of 10-15 pixels each. Region 1 represented the 
signals derived from atrial myocytes, region 2 the proximal AV node, region 3 the 
compact AV node and region 4 the His bundle region/AV nodal output (Figure 2-10). 
Regions were defined anatomically for each individual preparation. Absolute values 
of mean ± SEM Tact, Tpeak and TactM were then plotted and values compared between 
control and LVD samples. Furthermore, the conduction times between regions 
(atrial to AV node input, AV node input to compact node, compact node to His 
bundle) were determined and plotted. Activation time (Tact) was found to be the 
most reliable measurement and therefore data from the analyses of Tpeak and TactM 
are not shown.  
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Figure 2-10- Analysis of optical signals derived from the AV node. A – Photograph of the 
preparation in situ (AE – atrial electrode, CS – coronary sinus, tT – tendon of Todaro, HBE –His 
bundle electrode, * - compact AV node. B – CCD image of optically imaged region (1 – atrial 
tissue, 2 – AVN input/proximal AVN, 3 – compact AVN, 4 – His bundle region). C – Optically 
derived action potentials from regions 1-4. Note also atrial and His bundle surface electrograms 
(AE and HBE).  
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2.6 Histological analysis of the AV node 
Dr Patrizia Camelliti (University of Oxford) has undertaken histological analysis of 
the isolated AV node preparation to determine the expression of gap junction 
proteins (connexins) and their distribution in AV nodal tissue, and to determine the 
presence of any changes in connexin expression and/or distribution caused by LVD in 
our experimental model.  
At the end of the electrophysiology experiments, the isolated AV node preparations 
were further dissected to remove excess atrial tissue and remaining ventricular 
myocardium. The tissue was then placed on a coverslip rendered hydrophobic by 
coating with Repelcote. A fixative solution was then applied to the tissue and a 
further coverslip placed on top. The tissue sample was then snap frozen in liquid 
nitrogen and packaged in dry ice for transportation to the laboratory of Dr 
Camelliti, where it was sectioned and immuno-labelled for connexins 40, 43 and 45 
and neurofilament NF-160. 
2.7 Statistical analysis 
Power calculations predicted the estimated sample size required (N) at 10 
rabbits/group to detect a 20ms (20%) difference in the AH intervals between the 
control and LVD groups. (N=(2.SD2.power index)/? 2, where power index is equal to 
7.9 for 80% power to detect 2-sided significance at P<0.05 )(110) . 
Data were expressed as the mean ± standard error of the mean (SEM). Comparisons 
between two groups of data were made using Student’s t-test (paired where 
appropriate). Two-way ANOVA was used where appropriate to compare differences 
in the response of the controls versus LVD samples to interventions, such as the 
administration of a drug as well as to compare region by region conduction times in 
optical mapping experiments. A two-tailed p-value of less than 0.05 was considered 
statistically significant. 
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Chapter 3 - Atrioventricular nodal function in a 
rabbit model of left ventricular dysfunction 
 
Ashley M. Nisbet, 2008  Chapter 3; 64 
3 Atrioventricular nodal function in a rabbit model 
of left ventricular dysfunction  
3.1 Introduction 
3.1.1 Conduction abnormalities in CHF 
The prognosis in chronic heart failure is affected by conduction abnormalities 
affecting both the AV node and the His-Purkinje system (5-7;9;17). The mechanisms 
by which this occurs are not fully understood. Previous work from this laboratory 
has demonstrated delay in AV conduction in a rabbit model of left ventricular 
dysfunction (LVD)/heart failure due to chronic myocardial infarction (81). In this 
model, the infarct is localised to the left ventricular apex and there is no direct 
ischaemic insult to the basal myocardium. Using optical mapping, a mean increase 
of 20ms (20%) was found in the interval between right atrial stimulation and left 
ventricular epicardial activation in LVD hearts compared with controls (Figure 3-1). 
There was no decrease in left ventricular transmural or epicardial conduction 
velocity. The AV conduction delay increased with increasing pacing rates, suggesting 
that the site of increased delay was most likely to be the atrio-ventricular node. 
Initial histological analysis failed to demonstrate any gross changes in the tissue 
architecture of the AV node to account for this. The purpose of this study was to 
confirm that the exaggerated delay observed in LVD with respect to epicardial 
activation following right atrial stimulation was due to conduction delay within the 
AV node. Furthermore, this study aimed to study the effects of LVD on atrial and AV 
nodal refractory periods. Also, using standard pacing protocols, this study aimed to 
determine the prevalence of dual pathway AV nodal physiology in rabbit, and to 
identify any differences in slow or fast pathway conduction that might explain any 
exaggerated AV nodal delay in LVD. 
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Figure 3-1 –Time to earliest epicardial activation from right atrial pacing (reproduced from (81) 
with permission. This demonstrates the increase in delay of time from right atrial stimulus to 
epicardial activation in LVD, which increases with shorter pacing cycle lengths.  
 
3.1.2 Age as a contributor to AV nodal delay in CHF 
Atrioventricular conduction disorders have been recognised to occur with increased 
frequency with increasing age. Both cross-sectional and longitudinal studies of 
apparently healthy men and women have shown progressive prolongation of the PR 
interval on the electrocardiograph with advancing age (111;112). A further study, 
aiming to correlate the presence of ECG abnormalities with co-existing cardiac 
disease, showed that even in the absence of apparent underlying coronary or 
hypertensive heart disease, atrio-ventricular block occurred in patients = 65 years 
old (113). The prevalence was increased in men compared to women, and further 
increased in the presence of co-existing heart disease.  
Non-invasive investigation by means of high resolution signal averaged ECG in the 
context of age-related PR interval prolongation showed that the increase appeared 
to be due entirely to prolongation of the interval between the onset of the P wave 
to the His bundle signal, with no increase in the H-V interval. This suggests that age 
associated PR interval prolongation reflects delay at the level of the AV node (114). 
AV conduction is highly dependent on heart rate and autonomic tone, which is 
difficult to control for in human studies. Schmidlin et al (115) studied the effects of 
physiological aging on the cardiac electrophysiology of isolated, Langendorff 
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perfused Fischer 344 rat hearts, in the absence of potentially confounding 
autonomic influences. They demonstrated a significant decrease in heart rate with 
aging. Furthermore, spontaneous AV conduction times and AV conduction time 
during programmed stimulation increased significantly with aging. Wenckebach 
cycle length was also prolonged in senescent rats compared to younger animals. 
Histological analysis of the tissues demonstrated increased intercellular distance 
and increased collagen in the AV node, His bundle and summit of the 
interventricular septum. In 1995, another group studied the effect of aging on AV 
conduction in human subjects in the presence of autonomic blockade with atropine 
and propranolol (116). The findings concur with the animal study by Schmidlin et al. 
They found that in the presence of double autonomic blockade, the RR, PR, paced 
AV intervals and AV block cycle length were longer in older subjects. This confirms 
that in humans, heart rate and AV conduction prolongation exists with increasing 
age, and are independent of ß-adrenergic and/or parasympathetic influences.  
In the present study, there is progressive prolongation of the AH interval at all 
pacing cycle lengths in animals at 32 weeks post ligation (LVD (32)) compared to 
younger animals at 8 weeks post ligation (LVD (8)). As discussed above, age-related 
AV nodal conduction disturbance has been identified in both human and animal 
studies. The aim of this study was to examine the AV nodal conduction 
characteristics in a series of sham operated controls at 32 weeks post sham 
operation, and compare this with stock control animals (aged approximately 12 
weeks) to determine if age is a contributor to the more pronounced AV delay 
observed in LVD (32) compared to LVD (8). 
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3.2 Methods 
3.2.1 Rabbit model of LVD 
The rabbit model of LVD due to apica l myocardial infarction induced by coronary 
artery ligation as detailed in General Methods (Chapter 2) was used in this study. 
Sham operated animals underwent thoracotomy but not coronary ligation. 
Procedures were undertaken in accordance with the United Kingdom Animals 
(Scientific Procedures) Act 1986 and conform to the Guide for the Care and Use of 
Laboratory Animals published by the US National Institutes of Health (NIH 
Publication No. 85-23, revised 1985). Echocardiography was carried out prior to 
sacrifice to assess left ventricular systolic function determined by ejection fraction 
(LVEF) measured in long axis by M-mode. At 32 weeks, sham operated animals 
showed no evidence of left ventricular dysfunction, with a mean LVEF of 72.75 ± 
1.89%.  
Stock control animals did not undergo thoracotomy or echocardiography. 
Sham-operated animals, studied at 32 weeks post sham ligation (n=4), were 
compared to younger stock control animals, which were between 12 and 20 weeks 
old (n=14). Sham operations were performed at an age of 12-20 weeks, therefore 
the effective age of the Sham (32) animals was 44-52 weeks old. The results are 
discussed in detail below. 
3.2.2 The isolated AV node preparation 
The isolated AV node preparation was created as described in Chapter 2. 
3.2.3 Surface electrogram recording 
Electrograms recorded from the surface of the isolated atrioventricular node 
preparation were recorded using locally developed ECG acquisition software as 
previously described (NMap, Dr FL Burton, University of Glasgow). The spontaneous 
sinus cycle length was recorded in every experiment. The basic stimulus cycle 
length was 300ms. Atrio-Hisian (AH) intervals, Wenckebach cycle length, functional 
and effective refractory periods of the AV node and the atrial effective refractory 
periods were derived using standard pacing protocols and analysed as described 
earlier.  
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3.2.4 Optical mapping of activation 
The pattern of activation through the right atrial/AV node preparation was studied 
in a further series of 4 controls and 4 LVD samples (at 8 weeks post infarct) using 
the optical mapping methodology described earlier (see Chapter 2, General 
Methods). Hearts excised under terminal anaesthesia were loaded with RH237 via 
the coronary circulation via Langendorff perfusion. Thereafter the isolated right 
atrial preparation was prepared as previously described and mounted in a custom 
made chamber to allow superfusion with Tyrode’s solution of the above 
composition. The preparation was paced using protocols previously described to 
derive AH intervals and WCL. Surface electrograms and optically derived action 
potentials were recorded simultaneously.  
3.2.5 Analysis of optically derived action potentials 
Activation time (Tact) was defined as the time point of the maximum rate of rise of 
the AP upstroke (dF/dtmax), defined as the first derivative of the fluorescence 
signal. The mean ± SEM of Tact (ms) was determined in 4 distinct regions of the 
preparation, consisting of 10-15 pixels each (Figure 3-2). Region 1 represented the 
signals derived from atrial myocytes (around the pacing electrode), region 2 (A) the 
proximal AV node/AVN input, region 3 (B) the compact AV node and region 4 (C) the 
His bundle region/AV nodal output. Regions were defined anatomically and 
confirmed by the simultaneous presence of surface electrograms at the atrial and 
His bundle regions for each individual preparation. Absolute values of mean ± SEM 
Tact were then plotted and values compared between control and LVD samples. 
Furthermore, the conduction times between regions (atrial to AV node input, AV 
node input to compact node, compact node to His bundle) were determined and 
plotted. 
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Figure 3-2 – Typical optically derived action potentials from the isolated AV node preparation. 
Pacing electrode can be seen in the top left corner (atrial region). A – Proximal AV node/AVN 
input; B – Compact AV node; C – Distal AVN/His bundle.  
 
3.2.6 Statistical analysis 
3.2.6.1 Surface electrogram studies 
Results are expressed as mean ± SEM unless otherwise stated. Unless otherwise 
stated, comparisons between data derived from controls versus ligated preparations 
were made using an unpaired Student’s t-test. A two-tailed p-value of less than 0.05 
was considered statistically significant. 
3.2.6.2 Optical mapping studies 
A series of 4 LVD animals at 8 weeks post ligation were studied and compared to 4 
control animals. Results are expressed as mean ± SEM unless otherwise stated. 
Statistical analysis was based on analysis of variance (ANOVA) followed by t-tests 
corrected for multiple comparisons unless otherwise stated. A two-tailed p-value of 
less than 0.05 was considered statistically significant. 
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3.3 Results: In vivo data 
3.3.1 Baseline characteristics 
Previous work has shown that there are no significant differences in the 
haemodynamic or electrophysiological characteristics of stock animals versus sham 
operated controls studied at 8 weeks post sham ligation (81). “Control” animals 
were therefore stock animals, which had not undergone sham ligation. Baseline 
characteristics (body weight and left ventricular ejection fraction (LVEF)) of animals 
studied are summarised in Table 3-1. The mean body weight (Figure 3-3A) of the 
controls was 3.36 ± 0.6kg. The animals studied 8 weeks post coronary ligation (LVD 
(8)) weighed 3.56 ± 0.6kg (P<0.05), and those studied at 32 weeks post coronary 
ligation (LVD (32)) weighed 4.0 ± 0.2kg (P<0.01 when compared to LVD (8) and 
P<0.001 compared to control). A series of sham operated controls were studied at 
32 weeks post sham ligation (Sham (32)) to exclude age as a possible confounding 
factor. These animals weighed 3.91 ± 0.1kg (P=NS compared to LVD (32)).  
In keeping with previous studies (86), coronary ligation resulted in left ventricular 
systolic dysfunction as defined as a reduction in LVEF measured in short axis by M-
mode echocardiography (Figure 3-3B). Stock controls did not undergo 
echocardiography. Mean LVEF in LVD (8) was 44.88 ± 0.76% and in LVD (32) 43.56 ± 
0.99%. At 32 weeks, sham operated controls had a mean LVEF of 72.75 ± 1.89% 
(P<0.001 when compared to LVD (8) and (32)).  
 Control 
(n=60) 
LVD (8) 
(n=34) 
LVD (32) 
(n=9) 
Sham (32) 
(n=4) 
Body weight (kg) 3.36 ± 0.6 3.56 ± 0.6 4.0 ± 0.2 3.91 ± 0.1 
Ejection fraction 
(%) 
* 44.88 ± 0.76 43.56 ± 0.99 72.75 ± 1.89 
Table 3-1 - Baseline characteristics of the MI model as compared to stock and sham operated 
controls. LVD/Sham (8/32) – 8/32 weeks post infarct/sham ligation. Results expressed as mean ± 
SEM. (* control animals did not undergo echocardiography) 
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Figure 3-3– A – Bar chart of body weights of MI model animals compared to stock and sham 
operated controls. B – Bar chart of left ventricular ejection fraction in MI model as compared to 
sham operated controls. Results expressed as mean ± SEM. * P<0.05; ** P<0.01; *** P< 0.001.  
Ashley M. Nisbet, 2008  Chapter 3; 72 
3.3.2 Effect of LVD on the electrocardiographic markers of AV 
delay in vivo 
Surface ECG recordings (Figure 3-4) were carried out in a series of 8 sham operated 
animals and 8 LVD animals at 8 weeks post infarct to study the effect of coronary 
ligation on the in vivo markers of AV delay (namely PR interval). The data acquired 
allowed the analysis of the heart rate and therefore allowed the correlation of PR 
interval with RR interval across the series. 
 
Figure 3-4 – Example of surface ECG acquired from rabbits in this study. Paper speed 20ms per 
box on x-axis.  
 
There was a tendency towards higher heart rates in the LVD group compared to 
sham operated animals (Figure 3-5). The RR interval in the sham series was 143 ± 
24ms. In LVD the RR interval was 115 ± 10ms. The difference did not reach 
statistical significance. There was no difference in the mean PR interval between 
sham and LVD (Figure 3-5) (sham 26 ± 2ms and LVD 26 ± 2ms). 
Figure 3-6 shows a scatter plot of the mean ± SEM of the PR interval plotted against 
the corresponding RR interval for each animal in both sham and LVD series. This 
demonstrates the wider range of baseline RR intervals in the sham series compared 
to LVD. Linear regression analysis comparing sham with LVD failed to demonstrate 
any statistically significant difference in the relationship between RR and PR 
interval between the groups.  
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To determine whether there is any difference in the PR interval of LVD animals 
compared to sham at a given RR interval, a direct beat to beat comparison was 
made at a range of RR intervals between 130-135ms. This showed that the mean PR 
interval at RR 130-135ms was significantly longer in LVD compared to sham (31ms 
vs. 28ms, P<0.001, Figure 3-7). However, this should be interpreted with caution, as 
when analysed sample by sample (as opposed to beat to beat) there was no 
significant difference. It was not possible to analyse all samples at this heart rate 
due to the variation in baseline RR intervals. Further samples require to be studied 
at the given RR interval to provide enough power to detect a significant difference 
sample by sample.  
 
Figure 3-5 - Mean RR and mean PR interval on the surface ECG in vivo of sham versus LVD 
animals (n=8 in each group). P=NS. 
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Figure 3-6 - Correlation between the mean (± SEM) RR interval and the mean (±SEM) PR interval 
on the surface ECG in vivo for sham and LVD animals (n=8 in each group). 
 
 
Figure 3-7 - Beat to beat variation in PR interval on the surface ECG in vivo in sham versus LVD 
over range of RR intervals between 130-135ms. (Sham n=102 beats (4 animals); LVD n=243 beats 
(4 animals). ***P<0.001). 
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3.4 Results: The isolated AV node preparation 
3.4.1 Effect of LVD on spontaneous sinus cycle length 
The sinus node was kept intact to allow comparison of the spontaneous sinus cycle 
length (SSCL) between controls and LVD groups. There were no significant 
differences in the SSCL between controls and any other group, as summarised in 
Figure 3-8. The mean SSCL was: control 378.1 ± 13.6ms; LVD (8) 373.1 ± 23.2ms; 
LVD (32) 348.4 ± 23.5ms, and Sham (32) 354.3 ± 6.0ms.  
 
Figure 3-8 - – Spontaneous sinus cycle length in MI model compared to stock and sham operated 
controls. No significant differences were observed between any groups. Results expressed as 
mean ± SEM. 
 
3.4.2 Effect of LVD on AV node conduction characteristics 
The effects of LVD on AV node conduction characteristics were studied in a series of 
14 controls, 14 LVD (8) and 8 LVD (32) animals. AV node conduction was measured 
by plotting the A1H1 (AH) interval against the A1A1 interval using a pacing protocol 
of a drive train of 16 stimuli at a constant S1S1 interval of 300ms (Figure 3-9A) 
followed by a 1 second pause, before the S1S1 interval is decremented by 5ms. 
When the mean A1H1 interval for each corresponding A1A1 interval is plotted, 
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compared to controls there is an upwards shift of the AH interval in LVD (8), with a 
further upward shift in LVD (32) (Figure 3-9B). This represents prolongation of the 
AH interval at all tested pacing cycle lengths (PCL) in LVD compared to controls. 
The effect appears magnified at 32 weeks post ligation. 
 
Figure 3-9 – A – Ladder diagram of pacing protocol used to derive AV node conduction curves. B 
– AV node conduction curves of controls (n=14) and LVD at 8 (n=14) and 32 (n=8) weeks post 
infarct. Results expressed as mean ± SEM A1H1 at a range of pacing cycle lengths (A1A1).  
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In addition to an upwards shift in the AH interval in LVD, the Wenckebach cycle 
length is significantly longer in the LVD groups compared to controls. The effects of 
LVD on Wenckebach cycle length and AH intervals are summarised in Table 3-2. This 
demonstrates the statistically significant prolongation of the AH interval in LVD at 
both 8 and 32 weeks post ligation compared to controls at PCLs of 300ms and 200ms 
and the effect of LVD on Wenckebach cycle length. 
 Control LVD (8) Sham (32) LVD (32) 
WCL 129.3 ± 8.3 172.0 ± 13.6* 172.3 ± 12.8* 167.5 ± 13.7* 
AH300 43.6 ± 4.4 69.7 ± 8.8* 57.3 ± 8.9 77.4 ± 10.5** 
AH200 51.3 ± 5.3 77.5 ± 8.3* 68.3 ± 9.9 100.5 ± 15.6** 
Table 3-2 – Effect of LVD on AV node conduction characteristics. WCL - Wenckebach cycle length; 
AH300 - AH interval at PCL 300ms; AH200 - AH interval at PCL 200ms. Results expressed as 
mean ± SEM (ms). *P<0.05 **P<0.01. 
 
3.4.3 Effect of LVD on atrial and AV nodal refractory periods 
The functional (FRP) and effective (ERP) refractory periods of the AV node and the 
atrial effective refractory period were derived using the S1S2 pacing protocol 
described previously and illustrated in General Methods Figure 2-5. Samples which 
showed evidence of dual pathway AV nodal physiology were excluded from analysis 
of AV node refractory periods (excluded n=1 control, n=4 LVD (8) and n=2 LVD (32)). 
The effects of LVD on AV nodal FRP and ERP and atrial ERP are summarised in Table 
3-3. In LVD (8), the FRP was prolonged compared to controls, although this 
difference did not reach statistical significance. There was significant prolongation 
of the FRP in LVD (32) compared to controls. The ERP was prolonged in LVD (8) and 
(32) compared to controls, however there were no statistically significant 
differences between the groups.  
Atrial effective refractory period was determined in all samples and was not 
significantly prolonged in LVD compared to controls.  
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 Control LVD (8) Sham (32) LVD (32) 
FRP 145.1 ± 8.1 162.6 ± 15.6 140.6 ; 201.0 175.0 ± 8.4* 
ERP 110.6 ± 7.9 135 ± 12.1 121.0 ; 145.0 122.5 ± 10.7 
Atrial ERP 93.9 ± 6.5 84.8 ± 4.7 97.3 ; 63.3 94.3 ± 7.7 
Table 3-3 – Effects of LVD on AV nodal functional (FRP) and effective (ERP) refractory periods 
and atrial ERP. Results expressed as mean ± SEM, except where n=2 (individual values shown). 
*P<0.05. 
 
3.5 Results – Effects of ageing 
3.5.1 Effect of age on spontaneous sinus cycle length 
The sinus node was again kept intact to allow comparison of the spontaneous sinus 
cycle length (SSCL) between stock controls and 32 week sham operated controls. 
There were no significant differences in the SSCL between controls and Sham (32), 
as summarised in Figure 3-10. The mean SSCL was: control 378.1 ± 13.6ms and Sham 
(32) 354.3 ± 6.0ms.  
 
Figure 3-10 – Spontaneous sinus cycle length in 32 week sham operated animals (n=4) versus 12 
week controls (n=14). No significant differences were observed between the groups. Results 
expressed as mean ± SEM. 
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3.5.2 Effect of age on AV node conduction characteristics 
The effect of aging on AV node conduction characteristics was studied in a series of 
4 sham operated controls at 32 weeks post procedure, and compared with 12 week 
controls as detailed above. The AH intervals at pacing cycle length 300 and 200ms 
were prolonged in Sham (32) compared to 12 week controls, but this difference was 
not statistically significant. There was, however, significant prolongation of the 
Wenckebach cycle length in Sham (32) compared to 12 week controls (172.3ms vs. 
129.3ms, P<0.05). The results are detailed in Table 3-4.  
 
12 week 
Control 
Sham (32) 
WCL 129.3 ± 8.3 172.3 ± 12.8* 
AH300 43.6 ± 4.4 57.3 ± 8.9 
AH200 51.3 ± 5.3 68.3 ± 9.9 
Table 3-4 – Effect of aging on AV node conduction characteristics. WCL - Wenckebach cycle 
length; AH300 - AH interval at PCL 300ms; AH200 - AH interval at PCL 200ms. Results expressed 
as mean ± SEM (ms). *P<0.05.  
 
3.5.3 Effect of age on atrial and AV nodal refractory periods 
The functional (FRP) and effective (ERP) refractory periods of the AV node and the 
atrial effective refractory period were derived using the S1S2 pacing protocol 
described previously and illustrated in Chapter 2, Figure 2-5. Samples which showed 
evidence of dual pathway AV nodal physiology (n=1 12 week control, n=2 Sham (32)) 
were analysed separately to allow comparison of the refractory periods of both the 
slow and fast AV nodal pathways. 
The AV nodal FRP and ERP of Sham (32) was prolonged compared to control, 
however the results were not statistically significant due to the small number of  
samples. Only 4 Sham (32) animals were studied, and 2 of these showed evidence of 
dual pathway AV nodal physiology and were therefore excluded from the analysis 
Ashley M. Nisbet, 2008  Chapter 3; 80 
outlined in Table 3-5 below. Atrial ERP was not significantly different in the Sham 
(32) group compared to controls.  
 12 week Control Sham (32) 
FRP 145.1 ± 8.1 140.6 ; 201.0 
ERP 110.6 ± 7.9 121.0 ; 145.0 
Atrial ERP 93.9 ± 6.5 97.3 ; 63.3 
Table 3-5 - Effects of aging on AV nodal functional (FRP) and effective (ERP) refractory periods 
and atrial ERP. Results expressed as mean ± SEM (ms) (except where n=2 where individual 
values shown). Due to dual pathway AV nodal physiology, n=13 controls and n=2 Sham (32).  
 
The refractory periods of the slow and fast AV nodal pathways were then analysed 
in the remaining 2 Sham (32) animals and values were compared to the one control 
animal with evidence of dual pathway AV nodal physiology. Results are detailed in 
Table 3-6 below. There were no significant differences in slow or fast pathway FRP 
or ERP between the groups, although in the context of such small numbers 
statistical analysis must be interpreted with caution. 
 
 FRP ERP 
 Fast pathway Slow pathway Fast pathway Slow pathway 
12 week 
Control (n=1) 
161 276 145 116 
Sham (32) 
(n=2) 
206 ; 214 273 ; 245 137 ; 186 127 ; 142 
Table 3-6 - Refractory periods of fast and slow AV nodal pathways in 32 week sham controls 
versus stock controls exhibiting dual pathway AV nodal physiology. Individual values shown due 
to small sample size.  
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3.6 Results: Optical mapping of AV nodal conduction 
3.6.1 Effect of LVD on AV nodal conduction determined by optical 
mapping of activation 
Analysis of surface electrograms recorded during optical mapping experiments 
allowed measurement of the spontaneous sinus cycle length, AH intervals and 
Wenckebach cycle length in samples stained with RH237 with simultaneous optical 
data acquisition. Experiments were carried out in 4 controls and 4 LVD samples at 8 
weeks post infarct. As in previous studies there was no significant difference in the 
SSCL of controls versus LVD samples (Figure 3-11A). There was significant 
prolongation of WCL and AH interval across all PCLs in LVD compared to controls 
(Figure 3-11B and 3-11C). 
Figure 3-12 shows the surface electrograms and corresponding optical action 
potentials acquired during optical mapping experiments. Figure 3-13 documents the 
results of analysis of optically derived action potentials recorded from the isolated 
AV node preparation. Activation time (Tact) is significantly longer at the compact 
node and His bundle regions in LVD versus controls (P<0.001 by ANOVA). There is no 
significant difference in Tact at the atrial and AVN input regions between LVD and 
controls. The conduction times between regions (? Tact) are shown in Figure 3-13B, 
where 1= conduction time between the atrial and AVN input regions, 2= conduction 
time between the AVN input and compact AVN regions, and 3= conduction time 
between the compact AVN and His bundle regions. There is significant delay in 
conduction between the AVN input and compact nodal region in LVD compared to 
controls. When expressed as a ratio, there is an almost 4-fold increase in conduction 
time between AVN input and compact node in LVD compared to control, and a 3-
fold increase in conduction time between compact node and His bundle in LVD 
compared to control (Figure 3-13C).  
Figure 3-14 shows isochronal maps of activation at all three regions in one example 
each of control and LVD. It demonstrates conduction delay occurring initially at the 
proximal to compact nodal region in LVD with further delay between the compact 
node and His bundle of a greater extent in LVD compared to control. It is worth 
noting that the gap in the isochronal map corresponding to region 2 in control is a 
result of the position of the coronary sinus in the example analysed.  
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Figure 3-11 - Sinus rate and AV nodal conduction parameters from surface electrogram 
recordings during optical mapping experiments. A – Spontaneous sinus cycle length (SSCL); B – 
Wenckebach cycle length (WCL); C – AH intervals. Results expressed as mean ± SEM (msec). 
*P<0.05; **P<0.01. n=4 control and 4 LVD.  
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Figure 3-12 - Surface electrograms and optical action potentials (OAP) during regular pacing at 
250ms. A – stimulus artefact; B – atrial electrogram; C – OAP from atrial region; D – OAP from 
proximal AVN; E – OAP from compact AVN; F – OAP from His bundle region; G – His bundle 
electrograms followed by low amplitude ventricular signal. In F, the second peak of the OAP 
corresponds to the ventricular signal following the His electrogram as shown in G.  
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Figure 3-13 - A – Activation time (Tact) region by region. B – Change in activation time (?Tact) 
between adjacent regions. Results expressed as mean ± SEM (msec); n=4 control and 4 LVD. C - 
?Tact LVD / ? Tact Control. 1 = atrium to AVN input; 2= AVN input to compact AVN; 3 = Compact 
AVN to His bundle. There is significant prolongation of Tact in LVD at the compact node and His 
bundle regions compared to controls (ANOVA P<0.001). This is predominantly a consequence of 
significant delay in conduction between the AVN input and compact nodal region as shown in B 
above. ** P<0.01. 
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Figure 3-14 – Isochronal maps of activation in one example of control and LVD showing 
conduction slowing at region 2 (Proximal to compact AVN) and region 3 (Compact AVN to His 
bundle) in LVD compared to control. The key on the right is in milliseconds. Activation times are 
relative to the onset of the atrial electrogram.  
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3.7 Results: Evidence of dual pathway AV nodal 
physiology in rabbit 
In keeping with previous studies (42-44), we identified evidence of dual pathway AV 
nodal physiology in a number of animals, based on the presence of discontinuity of 
the AV nodal conduction curve, and functionally defined as an abrupt increase in 
the A2H2 interval of = 20ms in response to a 5ms decrement in A1A2 (Figure 3-15). 
 
Figure 3-15 – AV nodal conduction and refractory curves showing evidence of dual pathway AV 
nodal physiology. A – Discontinuity of the AV nodal conduction curve identifies slow pathway 
activation. B – Refractory curve identifies the fast pathway (FP) with an effective refractory 
period (ERP) of 130ms, and the slow pathway (SP) with an ERP of 75ms.  
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Dual pathway AV nodal physiology could be identified in both controls (22%) and LVD 
(33%) animals as summarised in Figure 3-13 (Chi-square, P=ns). When controls were 
subdivided into stock controls and sham operated controls, and LVD animals were 
subdivided into 8 and 32 weeks post ligation, there were no significant differences 
in the proportions of animals demonstrating evidence of dual pathway AV nodal 
physiology (Figure 3-16, Chi-square, P=ns). 
 
Figure 3-16 – A – Absolute numbers of samples displaying evidence of dual AV nodal physiology 
in controls (stock and sham operated) and LVD (8 and 32 weeks post infarct). B – expressed as a 
percentage of the total. P = ns.  
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Figure 3-17 – A - Absolute numbers of samples displaying evidence of dual AV nodal physiology 
subdivided by procedure: controls (stock and sham operated) and LVD (8 and 32 weeks post 
ligation). B – expressed as a percentage of the total. P = ns.  
 
In the study of the effect of LVD on AV nodal conduction characteristics, a number 
of samples were excluded from AV node refractory period analysis as explained 
above due to the presence of dual pathway AV nodal physiology. In these samples 
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the effective and functional refractory periods of the slow and fast pathways were 
determined, and are summarised in Table 3-7.  
 FRP ERP 
 Fast pathway Slow pathway Fast pathway Slow pathway 
Control (n=1) 161 276 145 116 
LVD (8) (n=4) 139.8 ± 9.4 186.8 ± 18.3 110.0 ± 9.4 80.3 ± 3.2 
LVD (32) 
(n=2) 
122 
143 
152 
161 
105 
115 
80 
98 
Table 3-7 – Refractory periods of fast and slow AV nodal pathways. Data expressed as mean ± 
SEM (ms) except where n=2 where individual data values shown.   
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3.8 Discussion 
In a rabbit model of LVD due to apical myocardial infarction, this study has 
confirmed that there is significant prolongation of AV nodal conduction delay at 
both 8 and 32 weeks post infarct. There was no effect of LVD on sinus node 
automaticity. The results and possible mechanisms underlying the findings are 
discussed in detail below.  
3.8.1 Effect of LVD on in vivo markers of AV delay 
A study of surface electrocardiograms from sham and LVD animals has demonstrated 
a non- significant increase in baseline heart rate in LVD but no difference in the 
overall mean PR intervals between the groups. Also, there was no significant 
difference in the overall relationship between the mean PR interval versus the mean 
RR interval between sham and LVD. When compared at a defined RR interval, there 
appears to be significant prolongation of the PR interval in LVD compared to sham. 
Further work on additional samples is required to study in more detail the relative 
difference in PR interval at each defined RR interval to confirm or refute this latter 
observation.  
In the isolated AV node preparation, in this rabbit model of LVD due to apical 
myocardial infarction, this study has confirmed that there is significant prolongation 
of AV nodal conduction delay at both 8 and 32 weeks post infarct. There was no 
effect of LVD on sinus node automaticity. The results and possible mechanisms 
underlying the findings are discussed in detail below.  
3.8.2 Effect of LVD on sinus node automaticity 
In the isolated right atrial/AV node preparation used in this study, the mean 
spontaneous sinus cycle length was not significantly altered by LVD, either at 8 or 32 
weeks post infarct. This is in contrast to findings of a previous study, in which a 
significant increase in the SSCL was observed in the presence of heart failure (117). 
However, the heart failure model in the study by Opthof et al (117) was induced by 
combined pressure and volume overload and not myocardial infarction as in the 
present study.  
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3.8.3 Effect of LVD on parameters of AV nodal function 
3.8.3.1 Effect of LVD on conduction time (AH interval and Wenckebach cycle 
length) 
In the present study, there is evidence of electrical remodelling of the AV node of 
rabbits with LVD due to chronic apical myocardial infarction. This was manifest by 
significant prolongation of the AH intervals at all tested pacing cycle lengths, with 
an upwards shift of the AV node conduction curve in LVD at both 8 and 32 weeks 
post infarct as illustrated by Figure 3-6B. The mean ± SEM AH intervals at all pacing 
cycle lengths in LVD (32) were further prolonged compared to LVD (8), but this 
difference was not statistically significant. Furthermore, there was significant 
prolongation of the Wenckebach cycle length in the LVD model at both 8 and 32 
weeks post infarct compared to controls. There was no progressive prolongation of 
the WCL at 32 weeks post infarct compared to 8 weeks post infarct.  
Given the heterogeneity of the AV node, the possible mechanisms by which 
conduction delay through the AV node is prolonged in LVD are likely to be multiple 
and complex. 
3.8.3.2 Beta-adrenergic down-regulation in heart failure  
In chronic heart failure, excess norepinephrine levels lead to downregulation and 
desensitisation of myocardial beta-adrenoceptors (74-76). The negative inotropic 
effect of chronic catecholamine excess and subsequent beta-adrenoceptor 
downregulation has been demonstrated in rabbit models using chronic isoprenaline 
infusion via the implantation of an osmotic minipump (77;78). Furthermore, 
previous work in our laboratory has demonstrated evidence of reduced ?-
adrenoceptor sensitivity to the inotropic effects of isoprenaline in papillary muscles 
from rabbits with LVD compared with sham operated controls (79). AV node 
conduction time depends on the interaction between the prevailing heart rate and 
the level of sympathetic tone, both of which exert opposite effects on AV 
conduction (118). In vivo, if the heart rate is held constant by artificial pacing, 
sympathetic stimulation decreases AV conduction time. However, an increase in 
heart rate by atrial pacing prolongs AV conduction time. Therefore, in response to 
chronic catecholamine excess in CHF, it may be that beta-adrenoceptor 
downregulation results in a reduction in the conduction velocity through the AV 
node. This hypothesis is explored further in a subsequent chapter. 
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3.8.3.3 Endogenous adenosine effects on the AV node  
Adenosine may signal conditions that are detrimental to the organism such as 
hypoxia. In cardiac hypoxia or ischaemia, adenosine formation occurs in both the 
cytosol of the cardiomyocyte and also in the extracellular space, possibly in the 
capillary endothelium (119). It reduces AV nodal excitability by inactivation of ICa,L 
and activation of a time-dependent inwardly rectifying potassium current (120-122). 
Furthermore, adenosine inhibits the potentially detrimental inotropic and metabolic 
effects of catecholamines released in response to myocardial ischaemia (123;124). 
Adenosine reduces myocardial oxygen demand by reducing sinus node automaticity 
and AV node conduction velocity via the adenosine A1 receptor subtype. This 
protective negative feedback mechanism is of importance in conditions of low 
oxygen supply to demand ratio. In the presence of a chronic myocardial infarction 
and left ventricular dysfunction, chronic excess endogenous adenosine release may 
explain the increase in AV nodal delay observed in this rabbit model. This hypothesis 
is also explored in more detail in subsequent chapters.  
3.8.3.4 Effect of LVD on atrial and AV nodal refractory characteristics 
The presence of LVD due to apical myocardial infarction did not alter the refractory 
characteristics of the atrial tissue, with no significant differences being observed in 
the atrial ERP of LVD at 8 or 32 weeks compared to control. The effect of LVD on 
conduction time from atrial to proximal AV nodal tissue and its contribution to the 
increase in AV conduction time in the rabbit model of LVD is explored using the 
technique of optical mapping, as discussed later. 
In the present study, mean AV nodal ERP and FRP were prolonged in LVD at 8 and 32 
weeks post infarct, however the results did not reach statistical significance (other 
than the AVN FRP in LVD (32) compared to control). This is likely to be a 
consequence of the lack of statistical power to detect the small increase in AV nodal 
refractoriness that occurs in LVD in the present series. Original power calculations 
were based on previous observations from this laboratory (81), namely a 20% 
increase in the AH interval in LVD, and did not account for changes in the FRP or 
ERP in the absence of preliminary observations. 
Reduction in conduction velocity through the AV node with a minimal effect on AV 
nodal refractoriness could occur as a consequence of reduced intercellular coupling. 
Connexin 43 is the major connexin in the working myocytes of the atria and 
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ventricles (125;126). Connexin 40 and 45 are the major connexins contributing to 
the spread of depolarisation through the AV conduction system (127-130).  
Hyperpolarisation-activated and cyclic nucleotide-gated channel 4 (HCN4), which 
has characteristic pacemaker activity, has been shown to be most abundant in the 
posterior nodal extension ((61;68). More recently, Yoo et al (68) confirmed the 
presence of the Na+ channel isoform Nav1.5 at the posterior nodal extension and the 
transitional zone between atrial and AV nodal cells. The gene responsible for Nav1.5 
is the SCN5A gene and inherited AV conduction disorders have been linked recently 
to mutations in this gene (64;65;67). In addition, SCN5A+/- mice exhibit impaired AV 
conduction (66). Alterations in connexin expression and/or distribution in AV nodal 
tissue in the context of LVD are a possible mechanism for the observed increase in 
AV delay in the present study. In collaboration with Dr Patrizia Camelliti, University 
of Oxford, this hypothesis is under investigation. 
3.8.4 Effect of ageing 
Another purpose of this chapter was to explore the possibility that age of the animal 
may be a contributor to the prolongation of AV delay observed in the LVD (32) 
group, given that there appeared to be progression of conduction delay compared to 
the LVD(8) group. Sham-operated animals, studied at 32 weeks post sham ligation, 
were compared to younger stock control animals, which were between 12 and 20 
weeks old. Sham operations were performed at an age of 12-20 weeks, therefore 
the effective age of the Sham (32) animals was 44-52 weeks old. The results are 
discussed in detail below. 
3.8.4.1 Effect of age on sinus node automaticity 
The isolated right atrial / AV nodal preparation used in this study removes the 
possibility of sympathetic/parasympathetic influence on the automaticity of the 
sinus node, therefore the sinus rate observed is truly “intrinsic”. In the present 
study, there were no significant differences in the spontaneous sinus cycle length in 
the stock controls versus the Sham (32) group. This is in contrast to the study of the 
effect of aging on Fischer 344 rats by Schmidlin et al (115) in which they 
demonstrated a significant decrease in heart rate in senescent rats. Human studies 
have also demonstrated prolongation of the RR interval with increasing age (116), 
even in the absence of autonomic inf luences. The lack of effect of age on the SSCL 
of the Sham (32) rabbit compared to younger animals in the present study may 
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represent a species specific difference compared to smaller rodents. Another 
possibility is that the age difference between the control group (12-20 weeks old) 
and the sham operated controls (44-52 weeks) may not be sufficient to affect sinus 
node automaticity in rabbit. The life expectancy of a healthy New Zealand White 
rabbit is between 5 and 7 years. Further studies in senescent rabbits may 
demonstrate an increase in the SSCL as has been observed in other species. 
3.8.4.2 Effect of age on parameters of AV nodal function  
In the present study there was a modest increase in the AH interval at PCL 300 and 
200ms in sham operated animals at 32 weeks compared to younger stock controls. 
The increase in AH interval was not statistically significant and was not of the same 
magnitude as that observed in animals that had undergone coronary ligation, at 
either 8 or 32 weeks post ligation. The Wenckebach cycle length was prolonged in 
Sham (32) compared to stock controls, and the increase was similar to that observed 
in both ligated groups (see Table 3-2, Chapter 3). Of note, in the study of the 
effects of LVD on AV nodal conduction, the Wenckebach cycle length did not get 
progressively longer at 32 weeks post ligation compared to that at 8 weeks post 
ligation. 
The AV nodal functional and refractory periods were prolonged in Sham (32) 
compared to stock controls, but due to the small sample size the results did not 
reach statistical significance. Previous authors have demonstrated age related 
prolongation of AVN ERP (131), although in this study the autonomic status of the 
patients was not controlled. 
Although every effort was made during experiments to minimise the ischaemic insult 
to the tissue, increased sensitivity to hypoxia in older samples may contribute to the 
observed prolongation of AV nodal conduction delay and WCL. The effects of graded 
hypoxia on AV nodal conduction in isolated perfused rabbit hearts was studied by 
Young et al (132). They compared adult and neonatal hearts and observed that in 
95% O2 the WCL was longer in adult compared to neonatal hearts, and increased 
much further in response to hypoxia in adult versus neonatal hearts. AH intervals 
began to increase at a higher O2 saturation (20%) in adult hearts versus neonatal 
(10%). 
The mechanisms whereby aging results in prolongation of AV nodal conduction delay 
have been explored in a number of studies of human AV nodal function. Wu et al 
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(133) showed that the cycle length of AV nodal re-entrant tachycardia was longer in 
an elderly population. Anselme et al (134) further investigated the modification of 
anterograde and retrograde activation associated with the aging process. The main 
finding of this study was that of slower retrograde conduction times in older 
patients due to selective regional slowing of conduction. There did not appear to be 
slowing of conduction in the “slow” pathway region but longer retrograde 
conduction occurred at all other recording areas. They concluded by suggesting that 
the delayed retrograde activation of the atrium is due to “transverse, non-uniform 
anisotropic conduction both in the circuit itself and between the exit from the 
circuit and the recorded atrial sites”. This may be a consequence of age-related 
microfibrosis within the AV nodal tissues. 
Age related microfibrosis of atrial tissue was found to result in reduction of 
transverse conduction velocity in a study by Spach and Dolber in 1986 (70). Using 
atrial tissue derived from humans at the time of cardiac surgery (chosen because of 
the anisotropic properties of the atrial pectinate bundles) they analysed both 
transverse and longitudinal extracellular and transmembrane action potentials to 
elucidate mechanisms of cardiac conduction disturbances that may ultimately lead 
to re-entry. They studied differences in waveforms between young and old patients. 
They found a smooth contoured waveform during transverse propagation in young 
patients but complex polyphasic waveforms in older patients. This was thought to 
be due to electrical uncoupling of the side-to-side connections of myocardial fibres 
with aging, resulting in a zigzag course of transverse propagation. Furthermore they 
observed collagenous septa separating groups of fibres. Consequently, there was a 
decrease in transverse conduction velocity with age, making it possible for re-entry 
to occur in small regions of cardiac tissue with apparently normal cellular 
electrophysiological properties.  
Lenegre or Lev’s disease (idiopathic progressive cardiac conduction disease) was 
initially described in 1963 (135;136). It is characterised by progressive age related 
AV conduction slowing, which may ultimately result in complete AV block 
necessitating permanent pacemaker implantation. Initially considered a primary 
degenerative disease of the conduction system, recently it has been linked to a loss 
of function mutation in the SCN5A gene encoding a cardiac Na+ channel (64). Studies 
of families carrying the gene revealed that the conduction defect worsened with 
age, and life threatening AV block occurring only in older patients. In order to study 
this in more detail a mouse model with targeted disruption of SCN5A was developed 
(137). Heterozygous mice (SCN5A+/-) demonstrate slowed conduction similar to that 
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in Lenegre’s disease patients, with progressive worsening of conduction defects 
(including P-wave, PR and QRS prolongation) with aging. Furthermore, histological 
analysis demonstrated fibrosis and expression of hypertrophy markers in older 
animals. In addition, connexin 40 expression was reduced by approximately 50% in 
SCN5A+/- mice compared to WT, which may explain slowed atrial and AV nodal 
conduction.  
In the present study of older, sham operated controls studied at age 44-52 weeks 
old, there was a modest but not statistically significant increase in the AH interval 
at PCL 300 and 200ms, and in AV nodal FRP and ERP compared to younger stock 
controls (age 12-20 weeks). Wenckebach cycle length was significantly longer in the 
older animals. There was no difference in the spontaneous intrinsic sinus cycle 
length between the groups. The lack of significant prolongation of SSCL, AH 
intervals and refractory periods is in contrast to previous human and animal studies. 
The rabbits used in this study were not senescent therefore age-related 
prolongation of SSCL and AV nodal conduction delay may still occur but may only be 
observed at an older age.   
3.8.5 Site of maximal AV delay – evidence from optical mapping 
studies 
Analyses of the surface electrograms acquired during optical mapping experiments 
confirmed the significant increase in AH interval and WCL in LVD compared to 
controls. It is interesting to note that the AH intervals at each PCL in LVD during this 
series of experiments appear strikingly longer than the intervals at corresponding 
PCLs in the surface electrograms series. The reason for this is not clear. Overall 
there is no statistically significant difference when the AH intervals in LVD from 
optical experiments are compared with the same from surface electrogram 
experiments. The lack of a similar discrepancy in the control AH intervals between 
the two series of experiments makes experimental technique (for example, use of 
the voltage sensitive dye, ischaemic time, duration of recordings) unlikely to be 
implicated.  
The results of optical mapping experiments show that the prolongation of AH 
interval in LVD compared to controls occurs as a result of conduction delay 
predominating between the AVN input and the compact node. There is also 
prolongation of conduction time between the compact node and the His bundle but 
this did not reach statistical significance. There is no difference in conduction time 
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from the atrial tissue to the AVN inputs. This strengthens the original hypothesis 
that the prolonged AV delay observed in LVD is due to conduction delay originating 
within the AV node, and is not a consequence of changes in conduction 
characteristics within atrial tissue.  
3.8.6 Evidence of dual pathway AV nodal physiology in rabbit 
Anatomical and functional studies of the rabbit AV node have confirmed the 
presence of two distinct input pathways into the AV node (40-44). In this study, 
there is also evidence of dual pathway AV nodal physiology in rabbit.  
Figure 3-17 illustrates the number and percentage of animals with evidence of dual 
pathway AV nodal physiology across all animals used for each study in this thesis. 
There was no significant difference in the proportion of animals exhibiting dual 
pathway AV nodal physiology between controls (33%) and LVD (22%) at either 8 or 32 
weeks post infarct. Activation of both slow and fast pathways was evident in both 
controls and LVD at 8 and 32 weeks post infarct. Therefore conduction block in the 
fast pathway with preferential slow pathway conduction is unlikely to explain the 
observed increase in AV delay in LVD.  
In the series of animals used to study the effect of LVD on AV nodal conduction 
characteristics, 1 control, 4 LVD (8) and 2 LVD (32) showed dual pathway AV nodal 
physiology. These animals were excluded from the analysis of AV nodal refractory 
periods. However, if the FRP and ERP of the fast pathway were input into the 
analysis, there were still no significant differences in refractory characteristics of 
the AV node between the groups. When the FRP and ERP of the fast and slow 
pathways were compared across the groups, there were no significant differences 
observed. This conclusion must be interpreted with caution in view of the small 
number of samples on which it is based. In particular there appeared to be an 
unusually long FRP and ERP in the control sample in which dual AV nodal physiology 
was observed (Table 3-7). This is inconsistent with data obtained from control 
animals compared to LVD animals shown previously, which suggested prolongation of 
the refractory periods of the AV node (although failing to reach statistical 
significance in most analyses) in LVD. This would suggest that the prolonged FRP and 
ERP in the control sample with dual AV nodal physiology was a spurious result that 
should be excluded from any conclusions.  
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3.8.7 Conclusion 
In summary, this study has confirmed that the exaggerated AV delay observed in the 
presence of LVD in this rabbit model is due to conduction delay at the level of the 
AV node. This occurs in the absence of significant prolongation of AV nodal 
functional or effective refractory periods. Atrial effective refractory period is not 
affected. There is no change in the conduction time between the atrium and the 
AVN input but significant delay in conduction between the AVN input and compact 
node and His bundle regions in LVD. The presence of dual pathway AV nodal 
physiology in similar proportions of controls and LVD hearts rules out preferential 
conduction via the slow pathway in LVD as a mechanism for the observation. Other 
hypotheses include a negative dromotropic effect on the AV node due to beta-
adrenoceptor down-regulation or chronic endogenous adenosine excess. The 
absence of significant prolongation of AV node refractory periods suggests reduction 
in conduction velocity due to changes in the electrotonic interaction between the 
cells of the AV conduction system, possibly through altered connexin expression. 
Subsequent chapters will investigate and discuss these hypotheses in more detail.  
Age related AV nodal delay may contribute to the observed further prolongation of 
AH intervals in LVD (32) animals compared to LVD (8). Indeed, mechanisms known to 
result in age-related AV nodal conduction delay may play a role in LVD induced AV 
nodal conduction delay. Histological analysis is being carried to identify the 
presence of microfibrosis and immunohistochemical analysis to determine the 
expression of connexins known to have a role in AV nodal conduction 
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Chapter 4 - Response of the sinus and AV nodes to 
beta-adrenergic stimulation in the rabbit model of 
LVD 
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4 Response of the sinus and AV nodes to beta-
adrenergic stimulation in the rabbit model of 
LVD  
4.1 Introduction 
In chronic heart failure, excess norepinephrine levels lead to downregulation and 
desensitisation of myocardial ?-adrenoceptors (74-76;138;139). The negative 
inotropic effect of chronic catecholamine excess and subsequent ?-adrenoceptor 
downregulation has been demonstrated in rabbit models using chronic isoproterenol 
infusion via the implantation of an osmotic minipump (77;78). Furthermore, 
previous work in our laboratory has demonstrated evidence of reduced ?-
adrenoceptor sensitivity to the inotropic effects of isoproterenol in papillary 
muscles from rabbits with LVD compared with sham operated controls (79).  
In the present study I have confirmed the presence of excessive AV nodal delay in 
the rabbit model of LVD due to apical myocardial infarction. The mechanisms 
underlying this conduction delay are uncertain but may include downregulation of ?-
adrenoceptors in AV nodal tissue. This would potentially have a negative 
dromotropic effect. The purpose of this study was to evaluate the chronotropic and 
dromotropic response to ?-adrenoceptor stimulation in controls and LVD animals at 
8 weeks post ligation (LVD (8)), and then to compare the responses to determine 
whether ?-adrenoceptor downregulation has a mechanistic role in the observed 
abnormal AV nodal delay in LVD.  
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4.2 Methods 
4.2.1 Rabbit model of left ventricular dysfunction due to apical 
myocardial infarction 
A well-characterised model of myocardial infarction (MI) induced by coronary artery 
ligation was used in this study as previously described (82-88). Procedures were 
undertaken in accordance with the United Kingdom Animals (Scientific Procedures) 
Act 1986 and conform to the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, revised 
1985).  
4.2.2 Isolated atrioventricular node preparation 
The isolated AV node preparation was created as described in Chapter 2.  
4.2.3 Isoproterenol concentration response study 
After 20-30 minutes of superfusion with normal Tyrode’s solution to allow 
equilibration, samples were superfused with isoproterenol in Tyrode’s solution of 
the above composition. The ?AH interval in response to isoproterenol reached 
steady state after 10 minutes of superfusion. Concentration response relationships 
for the chronotropic and dromotropic effects of isoproterenol were studied at 
increasing concentrations from 1x10-9M to 1x10-6M.  
4.2.4 Surface electrogram recording and pacing protocols 
Electrograms recorded from the surface of the isolated AV node preparation were 
recorded using locally developed ECG acquisition software (NMap, Dr FL Burton, 
University of Glasgow). The spontaneous sinus cycle length was recorded in every 
experiment. The basic stimulus cycle length was 300ms. Atrio-Hisian (AH) intervals, 
Wenckebach cycle length, functional and effective refractory periods of the AV 
node and the atrial effective refractory periods were derived using standard pacing 
protocols as described earlier. 
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4.2.5 Statistical analysis 
Results are expressed as mean ± standard error of the mean unless otherwise 
stated. The logEC50 of isoproterenol for each parameter was determined in each 
experiment. In addition, mean ± SEM values were determined for each parameter in 
response to each isoproterenol concentration increment. Overall response to 
isoproterenol was analysed by ANOVA. The values were then plotted against the 
log[isoproterenol] to generate the concentration response curve for each 
parameter. Unless otherwise stated, comparisons between data derived from 
controls versus ligated preparations were made using an unpaired Student’s t-test. A 
two-tailed p-value of less than 0.05 was considered statistically significant. 
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4.3 Results 
The chronotropic and dromotropic effects of isoproterenol were studied in a series 
of 7 control and 7 LVD (8) samples. This study was carried out in different animals 
to those reported in Chapter 3. Results are discussed in detail below. 
4.3.1 Chronotropic response to isoproterenol 
The spontaneous sinus cycle length at baseline was not significantly different 
between the control and LVD (8) groups (362.2 ± 27.75ms versus 343.9 ± 11.87ms) 
(Figure 4-1A). There was a progressive reduction in the spontaneous sinus cycle 
length with increasing isoproterenol concentration in both controls (ANOVA P<0.001) 
and LVD (8) (ANOVA P<0.001) (Figure 4-1B). There was no significant difference in 
the EC50 for isoproterenol between controls and LVD (8) (Table 4-1). Furthermore, 
the maximal response to isoproterenol was not significantly different between 
controls and LVD (8) (percent reduction in SSCL (mean ± SEM): control 33.55 ± 3.15% 
versus LVD (8) 40.65 ± 3.50%). 
 
Figure 4-1 – Chronotropic response to isoproterenol. A – SSCL at baseline in controls versus 
LVD (8). B – Concentration response curves of SSCL to isoproterenol in controls versus LVD (8). 
Results expressed as mean ± SEM. N=7 controls and 7 LVD (8). 
 
4.3.2 Isoproterenol effects on parameters of AV nodal function 
Preliminary data confirmed that the time to steady state AH interval at PCL 300ms 
in both control and LVD (8) was no longer than 10 minutes. Data were therefore 
recorded after 10 minutes of superfusion with each incremental concentration of 
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isoproterenol. Of note, the effects of isoproterenol at higher concentrations 
(3.1x10-7M and above) became unpredictable, particularly in the control samples, 
possibly because at this concentration the spontaneous sinus rate was faster than 
the PCL, affecting pacing capture. Due to this loss of pacing capture at PCL 300ms 
in 3.1x10-7M isoproterenol and above, data were excluded from the concentration 
response curve as illustrated in Figure 4-2B.  
At baseline, the mean ± SEM AH interval at PCL 300ms in control was 44.00 ± 4.48ms 
and in LVD (8) was 77.57 ± 16.35ms (P < 0.05, Figure 4-2A). Furthermore, at PCL 
200ms, the baseline AH interval was significantly longer in LVD (8) compared to 
control (control 58.00 ± 6.07ms versus LVD (8) 84.00 ± 12.59ms, P < 0.05, Figure 4-
2C). There was a progressive reduction in the AH intervals at both PCL 300ms 
(ANOVA control P=0.05; LVD (8) P=0.03) and 200ms (ANOVA control P=NS; LVD (8) 
P=0.04) with increasing isoproterenol concentration in both controls and LVD (8) 
(Figure 4-2B and 4-2D). The maximal response to isoproterenol was significantly 
greater in LVD (8) compared to controls at PCL 300ms (percent reduction in AH 
interval (mean ± SEM): control 9.98 ± 3.02% versus LVD (8) 23.69 ± 5.10%, P < 0.05). 
There was no significant difference, however, in the maximal response to 
isoproterenol at PCL 200ms between controls and LVD (8) (percent reduction in AH 
interval (mean ± SEM): control 13.96 ± 4.43% versus LVD (8) 18.81 ± 4.30%, P = ns). 
There was no significant difference in the EC50 for isoproterenol between controls 
and LVD (8) at either PCL 300ms or 200ms (Table 4-1). 
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Figure 4-2 – Effect of isoproterenol on AH intervals. A – Baseline AH intervals at PCL 300ms. B – 
Concentration response curve showing the effect of isoproterenol  on AH interval at PCL 300m s. 
C - Baseline AH intervals at PCL 200ms. D – Concentration response curve showing the effect of 
isoproterenol  on AH interval at PCL 200ms. Results expressed as mean ± SEM (ms). * P < 0.05. 
N=7 controls and 7 LVD (8). 
 
The Wenckebach cycle length at baseline was significantly longer in LVD (8) 
compared to control (191.4 ± 23.5ms versus 135.7 ± 9.4ms, P < 0.05) (Figure 4-3A). 
There was a progressive reduction in the Wenckebach length with increasing 
isoproterenol concentration in both controls (ANOVA P=NS) and LVD (8) (ANOVA 
P<0.001) (Figure 4-3B). There was no significant difference in the EC50 for 
isoproterenol between controls and LVD (8) (Table 4-1). However, the maximal 
response to isoproterenol was significantly greater in LVD (8) compared to controls 
(percent reduction in WCL (mean ± SEM): LVD (8) 27.3± 5.8% versus control 11.7 ± 
2.6%, P < 0.05). 
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Figure 4-3 – Effect of isoproterenol on Wenckebach cycle length. A – WCL at baseline in controls 
versus LVD (8). B - Concentration response curves of WCL to isoproterenol in controls versus 
LVD (8). Results expressed as mean ± SEM (ms). * P < 0.05. N=7 controls and 7 LVD (8).  
 
Due to the increase in spontaneous sinus cycle length in response to isoproterenol, 
refractory periods were determined at PCL 200ms. There were no significant 
differences in the AVN FRP, AVN ERP or atrial ERP at baseline between controls and 
LVD (8). There was no significant decrease in the AVN FRP, ERP or atrial ERP with 
increasing concentrations of isoproterenol. The EC50 of isoproterenol for all 
refractory periods was not significantly different between controls and LVD (8) 
(Table 4-1).  
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Table 4-1 – Log EC50 of isoproterenol. Results expressed as mean ± SEM (M). N=7 controls and 7 
LVD (8). 
 
Log EC50 Isoproterenol (M)  
Control LVD (8) 
P - value 
SSCL -7.78 ± 0.19 -7.74 ± 0.18 0.11 
WCL -8.93 ± 1.08 -8.22 ± 0.49 0.55 
AH300 -8.89 ± 1.88 -8.59 ± 0.80 0.92 
AH200 -7.15 ± 1.85 -8.98 ± 0.57 0.39 
AVN FRP -7.39 ± 0.53 -8.02 ± 0.45 0.40 
AVN ERP -7.73 ± 1.29 -9.49 ± 0.43 0.20 
Atrial ERP -7.33 ± 0.66 -6.15 ± 1.61 0.50 
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4.4 Discussion 
4.4.1 Evidence for ß-adrenoceptor downregulation in human studies 
and animal models of chronic heart failure 
Neurohormonal derangement has a central role in the pathogenesis of chronic heart 
failure. Increased circulating levels of catecholamines, especially norepinephrine, 
have been observed in the plasma of patients with CHF, and are strongly related to 
prognosis (140). In CHF, excess norepinephrine levels lead to downregulation and 
desensitisation of myocardial ?-adrenoceptors, the latter occurring by inhibition of 
receptor signalling pathways, increase in inhibitory G-proteins and decrease in 
adenylate cyclase and cAMP levels (74-76). The negative inotropic effect of chronic 
catecholamine excess and subsequent ?-adrenoceptor downregulation has been 
demonstrated in rabbit models using chronic isoprenaline infusion via the 
implantation of an osmotic minipump (77;78). Furthermore, previous work in our 
laboratory has demonstrated evidence of reduced ?-adrenoceptor sensitivity to the 
inotropic effects of isoprenaline in papillary muscles from rabbits with CHF 
compared with sham operated controls (79). Another group has shown evidence of 
progressive reduction in ß-adrenoceptor density in human ventricle (obtained via 
right ventricular endomyocardial biopsy or from LV free wall in explanted hearts of 
patients undergoing transplantation) with degree of LVSD, beginning with mild-
moderate LVSD (141). Furthermore, Ginsburg et al (142) demonstrated decreased 
response of failing human hearts to isoproterenol in RV papillary muscles isolated 
from normal and failing hearts. There was a significant decrease in the maximum 
tension generated by the failing hearts compared with normal. The EC50 for 
isoproterenol was fivefold higher in failing muscle compared with normal.  
4.4.2 Response of the sinus node to isoproterenol in the rabbit 
model of chronic heart failure 
The results of the present study show that isoproterenol had a positive chronotropic 
effect, with a concentration-dependent reduction in the spontaneous sinus cycle 
length. These findings are in keeping with other studies. Toda et al (143) studied 
the effect of sympathetic stimulation on transmembrane potentials in the SAN. 
Sympathetic nerve stimulation resulted in an increase in the pacemaker firing rate 
and in the slope of the slow depolarisation of the AP during diastole, as well as a 
decrease in the APD90. Similar effects were seen with the application of 
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norepinephrine, namely a concentration dependent decrease in the SAN cycle length 
with norepinephrine. Furthermore, Hewitt and Rosen (144) also observed a 
concentration dependent increase in sinus rate in isolated rabbit SAN tissue 
superfused with isoproterenol. The maximal reduction in SCL was comparable to the 
present study, at approximately –40% of baseline value. 
There is a paucity of literature reporting the effect of heart failure on the response 
of the sinus node to ß-adrenergic stimulation, although the effect of isoproterenol 
on sinus node rate has been studied in a rat model of cardiac hypertrophy induced 
by volume loading secondary to aortic incompetence (AI) (145). In isolated right 
atria, they observed a higher basal rate and a smaller effect of isoproterenol in AI 
animals compared to controls, suggesting down regulation of the ß-adrenoceptor 
pathway in this model (without overt heart failure). However, in this model, it has 
previously been shown that there was no alteration of the effect of isoproterenol on 
contractile force of papillary muscles and an unchanged number of ß-adrenoceptors 
in the ventricles of AI animals compared to controls, therefore this model is not 
really comparable to the MI model used in the present study. In the present study, 
the concentration response-relationship did not differ between the control group 
and the LVD group, with no significant difference being observed in the EC50 for 
isoproterenol between the groups. Furthermore, the maximal increase in the sinus 
node firing rate with isoproterenol was not significantly different between the 
groups.  
4.4.3 Effect of isoproterenol on dromotropic function in the 
atrioventricular node in the rabbit model of chronic heart 
failure 
Sympathetic stimulation results in an increase in conduction velocity through the AV 
node via ß-2 adrenoceptor mediated positive dromotropic effects (146). Given the 
evidence of ?-adrenoceptor downregulation and its potential therapeutic 
reversibility in respect of inotropic function, what evidence is there of analogous 
mechanisms affecting dromotropic function in the AV node? Elnatan et al (147) 
demonstrated a higher proportion of ?-adrenoceptors in the AV node than in the His 
bundle in hearts explanted from patients with idiopathic dilated cardiomyopathy 
and ischaemic heart disease. The lack of disease-free hearts prevented any 
comparison of the relative abundance of ?-adrenoceptors in disease states 
compared to controls. We hypothesised that ?-adrenoceptor downregulation may 
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result in a reduction in the conduction velocity through the AV node in CHF, and this 
may be evidenced by a relative reduction in the sensitivity of isolated AV nodal 
tissue from LVD animals to isoproterenol.  
The results of the present study confirm that superfusion with isoproterenol resulted 
in a concentration-dependent reduction in AV nodal conduction time (AH interval) in 
both controls and LVD samples. This finding was not influenced by heart rate as the 
intrinsic spontaneous sinus rate was overdriven by pacing at the Crista Terminalis. 
With this, there remained a concentration dependent reduction in the AH interval at 
both PCL 300ms and 200ms. Due to the increase in the spontaneous sinus rate at 
higher isoproterenol concentrations, there was failure of pacing capture at PCL 
300ms in concentrations of isoproterenol greater than 1x10-7M, precluding analysis 
of the AH interval under these conditions. The EC50 for the isoproterenol effect on 
AH interval was not significantly different between the groups, regardless of PCL. 
However, at the slower rate of PCL 300ms, the magnitude of the reduction in the AH 
interval with increasing isoproterenol concentration was significantly greater in the 
LVD group (24%) compared to control (10%). No similar difference was observed at 
PCL 200ms. This may reflect the inability of the rabbit AV node to facilitate a 
further increase in conduction velocity at this faster constant pacing rate in the 
presence of maximal ß-adrenergic stimulation, given that nodal conduction time is 
dependent on the complex interaction of a number of factors including the recovery 
time elapsed since the last activation and cumulative time and rate-dependent 
fatigue (148). During Wenckebach cycles, however, fatigue does not affect nodal 
conduction time and in fact facilitation increases from beat to beat allowing 
conduction at very short recovery intervals (55;148). In the present study the 
maximal reduction in Wenckebach cycle length was also significantly greater in the 
LVD group (27%) compared to control (12%). 
There have been no previous studies of the effect of isoproterenol on AV nodal 
conduction in the presence of AV nodal conduction delay in rabbit. Previous studies 
of the effects of isoproterenol on AV nodal conduction in patients with and without 
evidence of AV block have shown that AV nodal conduction delay may be reduced 
with ß-adrenergic stimulation (149). The AH interval was reduced with isoproterenol 
in both patients with normal and prolonged AV nodal conduction time. In two 
patients with second degree AV block proximal to the His bundle, 1:1 conduction 
was observed with isoproterenol. In individuals with normal AH interval at baseline, 
the AH interval was reduced by 21% with isoproterenol. In those with prolonged AH 
interval, the reduction with isoproterenol was 22%. There was no significant 
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difference in the magnitude of the effect of isoproterenol on AH interval in the 
presence of conduction delay compared to those with normal conduction, however 
conduction disease was not in the context of chronic myocardial infarction or heart 
failure.  
4.5 Conclusion 
This study suggests that the sensitivity of the rabbit AV node to exogenous ß-
adrenergic stimulation is in fact greater in the LVD model compared to controls 
when paced at cycle lengths similar to the spontaneous sinus cycle length. This 
novel finding is in contrast to the evidence of ß-adrenoceptor downregulation in the 
left ventricle of the same model as discussed above. There are a number of possible 
mechanisms which may underlie this, including the possibility of changes in the 
signalling system or an increase in the overall number of ?-adrenoceptors in the AV 
node. An alternative explanation could be that in LVD there is tonic depression of 
AV nodal conduction, for example  due to endogenous adenosine, which is overcome 
by the action of exogenously applied isoproterenol. Further work is required to 
clarify this. The lack of a difference in the EC50 for isoproterenol across the two 
groups suggests that the affinity of the AV nodal ß-adrenoceptors for the agonist was 
not different. However, the increase in the maximal reduction in AH interval and 
WCL may be due to enhanced efficacy of the agonist in LVD. This apparent up-
regulation of AV nodal ß-adrenoceptors in LVD due to apical MI may play an 
important role in the prevention of high degree AV block in vivo. 
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5 Influence of endogenous and exogenous 
adenosine on AV nodal conduction in the rabbit 
model of LVD  
5.1 Introduction 
It has been shown conclusively by many investigators that adenosine influences 
conduction time through the AV node (51;122;123;150-153). Conduction is slowed or 
even blocked as a consequence of the inhibitory action of adenosine on the action 
potential of nodal cells. Acting via the adenosine A1 receptor (119), adenosine 
hyperpolarises the membranes of AV nodal cells, reduces the slope of the upstroke 
and diminishes the amplitude of the AV nodal cell action potential (154;155).  
Adenosine is ubiquitous, as it is involved in the metabolism and catabolism of ATP 
(156;157). Release of adenosine may signal conditions that are detrimental to the 
organism, such as hypoxia (119), during which adenosine acts to minimise further 
tissue injury by reducing the myocardial oxygen demand, by reducing the sinus node 
automaticity and increasing conduction time through the AV node. Belardinelli et al 
(158) confirmed that release of endogenous adenosine was implicated in hypoxia 
induced AV conduction disturbances in the isolated perfused guinea pig heart, 
observing reversal of the hypoxia induced prolongation of the AH interval with the 
adenosine antagonist aminophylline. Further studies on adenosine and hypoxia 
effects on the rabbit AV node have also suggested that endogenous adenosine 
release is implicated in hypoxia induced AV nodal conduction delay (132). However, 
the magnitude of AH prolongation with hypoxia was significantly greater than that 
with even high (millimolar) concentrations of adenosine, suggesting that other 
factors may contribute to AV nodal delay in acute hypoxia. To date, no studies have 
been published investigating the role of endogenous adenosine in conduction 
abnormalities persisting after an acute hypoxic insult, such as the observed 
prolongation of the AH interval in our rabbit model of LVD due to chronic myocardial 
infarction. 
AV nodal conduction is determined in part by the balance of activation (by ß-
adrenergic stimulation) and inhibition (by adenosine) of adenylyl cyclase (159;160). 
As discussed in a previous chapter, in rabbits with AV nodal delay in the context of 
chronic myocardial infarction there is an increase in the maximal response of the AH 
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interval and Wenckebach cycle length to isoproterenol when compared to controls 
with normal AV conduction. The mechanism for this is unclear. Assuming that 
adenosine and ß-adrenergic agonists modulate AV nodal conduction by acting at the 
same point in the signalling pathway, i.e. at adenylyl cyclase (161), tonic 
conduction delay may have been caused by excess endogenous adenosine, which 
was then overcome in vitro by the application of a high concentration of 
isoproterenol.  
The aim of the present study was to determine whether chronic excess endogenous 
adenosine release is implicated in the observed prolongation of AV nodal 
conduction. This is investigated through the application of the selective adenosine 
A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (CPX), and comparison of 
its effects on the AV nodal functional characteristics in LVD (8) samples versus 
controls. A further aim of this study was to determine the presence of any 
differential response to exogenous adenosine in the LVD (8) samples compared to 
control.  
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5.2 Methods 
5.2.1 Rabbit model of left ventricular dysfunction due to apical 
myocardial infarction 
The rabbit model of LVD due to apical myocardial infarction induced by coronary 
artery ligation as detailed in Chapter 2 was used in this study. Sham operated 
animals underwent thoracotomy but not coronary ligation. Procedures were 
undertaken in accordance with the United Kingdom Animals (Scientific Procedures) 
Act 1986 and conform to the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, revised 
1985).  
5.2.2 The isolated AV node preparation 
The isolated AV node preparation was created as described in Chapter 2.  
5.2.3 Surface electrogram recording 
Electrograms recorded from the surface of the isolated AV node preparation were 
recorded using locally developed ECG acquisition software (NMap, Dr FL Burton, 
University of Glasgow). The spontaneous sinus cycle length was recorded in every 
experiment. The basic stimulus cycle length was 300ms. Atrio-Hisian (AH) intervals, 
Wenckebach cycle length, functional and effective refractory periods of the AV 
node and the atrial effective refractory periods were derived using standard pacing 
protocols as described earlier.  
5.2.4 Effect of 8-cyclopentyl-1,3-dipropylxanthine (CPX) – a 
selective adenosine A1 receptor antagonist. 
The selective adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine 
(CPX) (Sigma, St Louis) was applied to preparations to determine whether release of 
endogenous adenosine contributes to AV nodal delay in this isolated right atrial 
preparation in vitro. After 20-30 minutes of superfusion with normal Tyrode’s 
solution to allow equilibration, samples were superfused with CPX in Tyrode’s 
solution of the above composition. The relative change in spontaneous sinus cycle 
length, Wenckebach cycle length, AH interval, and atrial and AV nodal functional 
Ashley M. Nisbet, 2008  Chapter 5; 116 
and effective refractory periods were determined after superfusion for 5 minutes 
with CPX. Responses were determined at baseline, and in CPX concentrations of 
0.01, 0.1 and 1µM. 
5.2.5 Effect of exogenous adenosine on AV nodal conduction 
In a further series of controls and LVD (8) samples the effect of exogenous 
adenosine (Sigma, St Louis) on AV nodal conduction was studied. After 20-30 
minutes of superfusion with normal Tyrode’s solution to allow equilibration, samples 
were superfused with adenosine in Tyrode’s solution of the above composition. 
Preliminary studies confirmed that the maximal ?AH interval reached steady state 
after 15 minutes of superfusion with adenosine in both controls and LVD (8) 
samples. The change in Wenckebach cycle length and AH interval at PCL 300ms and 
200ms were therefore determined after superfusion for 15 minutes with adenosine. 
Responses were determined at baseline, and in adenosine concentrations of 0.1, 1, 
5, 10 and 20µM. 
To confirm that the response to exogenous adenosine could be reversed, samples 
were then superfused with progressively increasing concentrations of CPX (0.01, 0.1 
and 1µM) following data acquisition in the maximal concentration of adenosine. The 
changes in Wenckebach cycle length and AH interval were again determined after 
superfusion for 5 minutes with each incremental dose of CPX. 
5.2.6 Statistical analysis 
Results are expressed as mean ± standard error of the mean unless otherwise 
stated. Mean ± SEM values were determined for each parameter in response to each 
CPX and adenosine concentration increment. Statistical analysis was based on 
analysis of variance (ANOVA) followed by t-tests corrected for multiple comparisons 
unless otherwise stated. A two-tailed p-value of less than 0.05 was considered 
statistically significant. 
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5.3 Results 
5.3.1 Effect of 8-cyclopentyl-1,3-dipropylxanthine (CPX) on sinus 
rate and AV nodal conduction 
The effect of CPX on sinus rate and AV nodal conduction and refractory periods was 
studied in a series of 4 control and 4 LVD (8) samples. Results are expressed as the 
mean ± SEM percentage change from the baseline value (Table 5-1 and Table 5-2). 
Figure 5-1A illustrates the effect of CPX on the spontaneous sinus cycle length. 
There was no significant change in the SSCL compared to baseline with increasing 
concentrations of CPX in either controls or LVD (8) (Figure 5-1A). There was no 
significant difference between groups in the effect of CPX on SSCL (ANOVA P = 
0.79). Figure 5-1B illustrates the effect of CPX on Wenckebach cycle length. There 
was no significant change in the WCL compared to baseline with increasing 
concentrations of CPX in either controls or LVD (8). Furthermore, there was no 
significant difference between the groups in the effect of CPX on WCL (ANOVA P = 
0.73).  
 
Figure 5-1 – A – effect of CPX on spontaneous sinus cycle length (SSCL) ANOVA P = 0.79. B– 
effect of CPX on Wenckebach cycle length (WCL) ANOVA P = 0.73. Results expressed as mean ± 
SEM. N=4 controls and 4 LVD (8). 
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? (mean (SEM) %) from 
baseline 
 
[CPX] (µM) 
Control  LVD (8)  
P value 
0.01 -1.3 (3.6) 3.2 (18.8) >0.05 
0.1 -1.7 (3.8) 2.3 (19.1) >0.05 SSCL 
1 -2.3 (4.4) 5.6 (21.2) >0.05 
0.01 -6.8 (4.5) -0.8 (0.8) >0.05 
0.1 -3.9 (8.0) -3.5 (4.9) >0.05 WCL 
1 -5.3 (7.6) -3.8 (5.0) >0.05 
0.01 -5.3 (5.0) -3.6 (3.5) >0.05 
0.1 -5.9 (5.3) -5.0 (1.2) >0.05 AH300 
1 -7.3 (4.0) -7.0 (1.4) >0.05 
0.01 -1.7 (2.9) -3.4 (3.4) >0.05 
0.1 -4.7 (3.9) -6.5 (1.9) >0.05 AH200 
1 -5.8 (4.2) -10.1 (2.6) >0.05 
0.01 -16.2 (9.9) -7.4 (4.2) >0.05 
0.1 -16.7 (9.0) -5.6 (4.0) >0.05 AH100 
1 -18.5 (7.0) -7.7 (7.7) >0.05 
Table 5-1 – Response to CPX in controls (n=4) versus LVD (8) (n=4). There were no significant 
differences between controls and LVD (8) for each parameter at each [CPX] as shown. Results 
expressed as mean (SEM).  
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The effect of CPX on the AH interval was determined at 3 pacing rates: PCL 300, 200 
and 100ms. Results are shown in Figure 5-2 below. Overall, with increasing 
concentration of CPX, the mean effect was of a progressive reduction in the AH 
interval at all tested pacing cycle lengths, although this did not reach statistical 
significance. At PCL 300ms, there was no significant change in the AH interval 
compared to baseline with increasing concentrations of CPX in the control group. 
Analysis of variance showed no significant difference in the magnitude of effect 
between controls and LVD (8) across all concentrations (P = 0.86). 
At PCL 200ms, there was no significant change in the AH interval compared to 
baseline with increasing concentrations of CPX in controls or LVD (8). Again, analysis 
of variance showed no significant difference in the magnitude of effect between 
controls and LVD (8) (P = 0.61). 
Due to the onset of conduction block at PCL 100ms, AH interval could not be 
determined for 1 control and 2 LVD (8) samples at this rate. It was therefore not 
possible to perform analysis of variance to compare groups. At each concentration, 
however, an unpaired t-test revealed no significant difference between groups.  
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Figure 5-2 – A – effect of CPX on AH interval at PCL 300ms (n=4 control and n=4 LVD (8), ANOVA 
P = 0.86). B – PCL 200ms (n=4 control and n=4 LVD (8), ANOVA P = 0.61). C – PCL 100ms (n=3 
control and n=2 LVD (8) P = ns at each concentration).  Results expressed as mean ± SEM (%). 
Individual data points shown where n=2.  
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AV nodal functional and effective refractory periods and atrial effective refractory 
period were determined at a basic PCL of 300ms. Results are shown in Table 5-2 and 
Figure 5-3 below. CPX did not significantly alter the AVN FRP, ERP or atrial ERP from 
baseline at any concentration. Furthermore, there were no significant differences in 
the AVN FRP, ERP or atrial ERP between controls and LVD (8) at any concentration.  
? (mean (SEM) %) from 
baseline 
 
[CPX] (µM) 
Control LVD (8) 
P value 
0.01 -3.5 (10.6) 2.1 (2.2) >0.05 
0.1 1.0 (9.1) 0.7 (3.0) >0.05 AVN FRP 
1 0.2 (8.3) 0.8 (3.2) >0.05 
0.01 -8.8 (13.3) 14.2 (7.1) >0.05 
0.1 -13.5 (13.8) 11.2 (4.6) >0.05 AVN ERP 
1 -15.4 (17.5) 13.9 (7.9) >0.05 
0.01 -2.5 (12.7) 9.5 (4.0) >0.05 
0.1 3.3 (5.0) 10.5 (3.2) >0.05 Atrial ERP 
1 2.5 (6.3) 12.0 (8.1) >0.05 
Table 5-2 – Response to CPX in controls versus LVD (8) – Refractory periods. There were no 
significant differences between controls and LVD (8) for each parameter at each [CPX] as shown. 
Results expressed as mean (SEM). N=4 controls and 4 LVD (8). 
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Figure 5-3- A - Effect of CPX on AV nodal FRP (ANOVA P = 0.94). B - Effect of CPX on AV nodal 
ERP (ANOVA P = 0.15). C – Effect of CPX on atrial ERP (ANOVA P = 0.31). Results expressed as 
mean ± SEM (%). N=4 controls and 4 LVD (8).  
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5.3.2 Dromotropic effect of adenosine: comparison between 
controls and LVD (8) 
To characterise the negative dromotropic action of adenosine, and thus identify any 
difference in response between controls and LVD (8), atrial rate was held constant 
by pacing at 300ms, 200ms and 100ms cycle lengths (after decrementing the pacing 
rate to determine the Wenckebach cycle length). Preliminary experiments 
confirmed that the maximal ?AH interval in response to superfusion with adenosine 
(concentration 20µM) reached steady state after 15 minutes. Therefore, after 20-30 
minutes of superfusion with Tyrode’s solution of the composition outlined above to 
allow equilibration, samples were superfused with adenosine in Tyrode’s solution in 
progressively increasing concentrations (0.1, 1, 5, 10 and 20µM). Data were acquired 
after 15 minutes of superfusion at each concentration.  
Table 5-3 summarises the results of the comparison of the negative dromotropic 
effect of adenosine on controls (n=6) versus LVD (8) (n=4). The negative 
dromotropic effect of adenosine was minimal in control samples. At PCL 300ms, the 
maximum mean ±SEM increase in the AH interval was 2.3 ±1.2ms in [adenosine] 
20µM. At PCL 200ms, the maximum mean ± SEM increase in the AH interval was 2.3 
± 0.8ms. The negative dromotropic effect of adenosine was much more pronounced 
in LVD (8) samples. At PCL 300ms, the maximum mean ± SEM increase in the AH 
interval was 7.3 ±4.9ms in [adenosine] 20µM. At PCL 200ms, the maximum mean ± 
SEM increase in the AH interval was 12.5 ± 4.9ms. Overall, adenosine had a 
significantly greater negative dromotropic effect in LVD (8) compared to controls at 
both PCL 300 and 200ms (ANOVA P < 0.05 and P < 0.01, Figure 5-4A and 5-4B 
respectively). At concentrations > 0.1µM, the magnitude of effect of adenosine was 
significantly greater in LVD (8) compared to controls at the faster pacing rate of PCL 
200ms compared to PCL 300ms. The magnitude of effect of adenosine in 
prolongation of the Wenckebach cycle length was much greater in LVD (8) than in 
controls (ANOVA P < 0.01, Figure 5-4C). There was no significant change from 
baseline WCL in controls with increasing concentrations of adenosine. However, in 
LVD (8), at [adenosine] 5µM and above, there was significant prolongation of the 
WCL compared to control (Figure 5-4C).  
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? (mean (SEM) (ms)) from 
baseline 
 
[Ado] (µM) 
Control LVD (8) 
P value 
0.1 -1.2 (1.2) 5.0 (4.0) > 0.05 
1 0.7 (0.8) 6.5 (5.0) > 0.05 
5 0.8 (0.5) 7.3 (5.0) > 0.05 
10 0.7 (0.9) 7.3 (5.3) > 0.05 
AH300 
20 2.3 (1.2) 6.3 (4.9) > 0.05 
0.1 -1.0 (1.3) 0.8 (0.8) > 0.05 
1 -1.2 (0.8) 8.8 (4.3) < 0.05 
5 1.2 (1.1) 10.8 (4.5) < 0.05 
10 1.0 (1.0) 11.0 (4.2) < 0.05 
AH200 
 
20 2.3 (0.8) 12.5 (4.9) < 0.05 
0.1 2.0 (2.0) -3.3 (3.3) > 0.05 
1 0.0 (3.2) 35.0 (22.6) > 0.05 
5 -3.6 (2.6) 40.0 (20.0) < 0.05 
10 2.0 (3.4) 53.3 (19.2) <0.01 
WCL 
20 2.0 (5.8) 46.6 (20.2) <0.01 
Table 5-3 - Response to Adenosine (Ado) in controls (n=6) versus LVD (8) (n=4). Results 
expressed as mean (SEM) (ms).  
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Figure 5-4 – Negative dromotropic effect of adenosine. A – AH interval at PCL 300ms. B – AH 
interval at PCL 200ms. C – Wenckebach cycle length. Results expressed as mean ± SEM (ms). 
N=6 controls and 4 LVD (8). 
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5.3.3 Reversal of the effect of adenosine with CPX 
As outlined above, the administration of CPX to this isolated tissue preparation had 
no significant effect on parameters of sinus rate, AV nodal conduction or refractory 
periods of the AV node or atrium in either controls or LVD (8) samples. This may 
have been a result of lack of tissue sensitivity to the concentrations used, or simply 
because there was insufficient endogenous adenosine present affecting AV 
conduction time. Therefore to confirm that this preparation was responsive to CPX, 
namely CPX was capable of reversing the effect of exogenous adenosine, it was 
added in progressively increasing concentrations (0.01, 0.1 and 1µM) following the 
adenosine concentration response studies. 
Following data acquisition in [adenosine] 20µM, samples were superfused with CPX 
in Tyrode’s solution as outlined in Methods. Data were then acquired after 5 
minutes of superfusion with each incremental concentration of CPX. Superfusion 
with adenosine continued during CPX superfusion. Results are summarised in Figure 
5-5 below.  
The AH interval prolongation that occurred in response to adenosine at PCL 300ms 
and 200ms was reversed back to baseline with [CPX] 0.01µM and remained at this 
level with increasing concentrations of CPX (Figure 5-5A and 5-5B). This effect was 
seen in both controls and LVD (8) samples.  
In controls, Wenckebach cycle length did not change significantly with adenosine or 
with the addition of CPX. In LVD (8), the prolongation of WCL induced by adenosine 
was reversed back to baseline with [CPX] 0.01µM and remained at this level with 
increasing concentrations of CPX (Figure 5-5C). 
These results confirm that the isolated AV node preparation was in fact responsive 
to CPX in the presence of exogenous adenosine. Furthermore, it suggests that the 
presence of excess endogenous adenosine does not contribute to the observed 
prolongation of AV nodal conduction time in the rabbit model of LVD.  
Ashley M. Nisbet, 2008  Chapter 5; 127 
 
Figure 5-5 – Reversal of the effect of adenosine with CPX. Data at baseline represents pre-
adenosine. Superfusion with adenosine 20µM continued during CPX experiments. Results 
expressed as mean ± SEM (ms). N=6 controls and 4 LVD (8). 
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5.4 Discussion 
5.4.1 Role of endogenous adenosine in abnormal AV nodal delay in 
the rabbit model of LVD 
Adenosine released after acute myocardial ischaemia has an important 
compensatory role in the inhibition of the detrimental metabolic and inotropic 
effects of catecholamines (123;124;161;162). To date, no studies have been 
published investigating the role of adenosine in the development of conduction 
abnormalities in chronic heart failure, such as may be caused by acute myocardial 
infarction. The aim of the present study was to determine whether chronic excess 
endogenous adenosine release is implicated in the observed prolongation of AV 
nodal conduction time in our rabbit model of LVD due to chronic myocardial 
infarction. This was investigated by superfusion of a known specific adenosine A1 
receptor antagonist, CPX, onto the isolated AV node preparation in increasing 
concentrations. There were no significant changes in the SSCL, WCL or AH intervals 
from baseline with increasing concentrations of CPX. The reasons for the lack of 
effect of CPX are not clear but are considered in detail below. 
It is possible that the lack of effect of CPX reflects simply the absence of tonic 
excess endogenous adenosine activity in the isolated AV node preparation. 
Circulating adenosine has a very short half-life of adenosine in plasma and 
presumably in the interstitial space between cells (1 to a few seconds)(163;164). 
However, the hypothesis was that local, paracrine adenosine release accounted for 
the increase in AH interval. The lack of effect of CPX is unlikey to reflect the rapid 
de-amination or breakdown of endogenous adenosine when the heart is excised and 
the tissue sample dissected, as this paracrine release of adenosine would be 
expected to continue. The possibility of a methodological error resulting in the 
absence of tissue sensitivity to CPX was excluded by the observation of reversal of 
the effect of exogenously applied adenosine. 
The absence of any change in sinus rate or AH interval in the presence of CPX alone 
provides additional information regarding the integrity of the isolated AV node 
tissue sample. If the sample were significantly hypoxic, one would expect the 
release of endogenous adenosine in response to hypoxia, resulting in prolonged SSCL 
and AV nodal conduction time, effects that would reverse in the presence of CPX. 
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5.4.2 Differential effect of adenosine on AV nodal conduction in the 
rabbit model of LVD. 
In control samples, adenosine had a minimal effect on the AH intervals and WCL, 
with a maximal increase in the AH interval of 6ms at the maximum concentration 
tested (20µM). The protocols in the present study were carried out at 37oC. Previous 
investigators have confirmed that there is variation in the effect of adenosine across 
species, with rabbit hearts being less responsive to adenosine than guinea pig hearts 
(157). In this study, Froldi and Belardinelli observed mean prolongation of stimulus 
to His bundle interval of less than 10ms in rabbit versus around 30ms in guinea pig 
hearts in 20µM adenosine. However, the experiments were carried out at 35oC. 
Other investigators have studied AV nodal responses to adenosine at even lower 
temperatures (34oC), (158) due to the decreased sensitivity of the preparation to 
adenosine at higher temperatures (165).  
When measured in the effluent of isolated tissue samples, the amount of adenosine 
released in response to hypoxia is in the sub-micromolar range. The magnitude of 
AV nodal conduction slowing during hypoxia is much greater than that seen when 
similar concentrations of exogenous adenosine are applied (121;166). However, 
when adenosine de-amination and re-uptake are inhibited, the concentration-
response relationship becomes similar to that seen in hypoxia (154). In the present 
study, the magnitude of response to adenosine was much greater in LVD (8) samples 
compared to controls, and was to the extent seen by previous investigators at cooler 
temperatures or during hypoxia. This may be a consequence of down-regulation of 
the signalling pathways responsible for adenosine metabolism in the LVD model.  
The maximal increase in the AH interval was greater with increased pacing rate 
(Figure 5-4A and 5-4B) in keeping with previous investigators observations (157;158). 
This may be a consequence of the additional effect of endogenous adenosine 
release during rapid pacing (167). There was a significant prolongation in the WCL in 
LVD (8) in response to adenosine. This reflects adenosine’s action on the N-cells of 
the AV node, inhibiting ICa,L and activating of IK,Ado (168) resulting in rate dependent 
activation failure at lower rates in LVD (8). This increased sensitivity of the AV node 
of LVD (8) samples to adenosine may have additional anti-arrhythmic properties, 
protecting the impaired ventricle from rapid atrial rates as may be caused by supra-
ventricular tachy-arrhythmias such as atrial fibrillation. 
Ashley M. Nisbet, 2008  Chapter 5; 130 
5.5 Conclusion  
In summary, in the rabbit model of LVD due to chronic myocardial infarction, there 
was no evidence of chronic endogenous adenosine excess contributing to prolonged 
AV nodal conduction time. It is not clear, however, if this represents an absence of 
endogenous adenosine or rapid reversal of its effects on excision of the heart due to 
its short half life. There was however an increase in the effect of exogenous 
adenosine in the LVD model compared to controls, which may be due to adaptive 
responses serving to protect the impaired ventricle from rapid atrial rates. Further 
work is required to establish the mechanisms underlying these observations.  
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Chapter 6 - Effect of acidosis on the 
electrophysiology of the atrioventricular node 
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6 Effect of acidosis on the electrophysiology of 
the atrioventricular node  
6.1 Introduction 
6.1.1 Clinical significance of myocardial acidosis 
It has been recognised that for over 100 years a decrease in extracellular pH has 
detrimental effects on cardiac function (169), being negatively inotropic (170) and 
potentially arrhythmogenic (171). Clinical disturbances of acid-base status can 
result in global myocardial acidosis, such as the metabolic acidosis associated with 
diabetic ketoacidosis or the respiratory acidosis associated with hypoventilation and 
hypercapnia. Furthermore, myocardial hypoperfusion, irrespective of aetiology, can 
result in global myocardial acidosis. Regional myocardial acidosis occurs as a 
consequence of myocardial ischaemia, most commonly as a result of acute occlusion 
of a coronary artery. Abrupt cessation of blood flow and therefore oxygen supply to 
the myocardium results in a profound decrease in intracellular pH by the 
mechanisms outlined below. 
6.1.2 Cellular response to acidosis induced by ischaemia 
Two processes contribute to the electrophysiological changes in ischaemia, namely 
loss of oxygen and nutrient supply, and failure to clear the cell’s extracellular space 
of its metabolites (172). Normally cardiomyocytes derive energy from oxidative 
metabolism of glucose and fatty acids, with a minimal contribution from anaerobic 
glycolysis. Ischaemia shifts the cell metabolism to anaerobic glycolysis due to loss of 
oxygen, which halts the tricarboxylic acid cycle. This transition has several 
important consequences (173). The breakdown of glycogen produces pyruvic acid, 
which cannot enter the TCA cycle. Intracellular pH falls as protons are produced 
during hydrolysis of ATP and accumulate during production of lactic acid. 
Extracellular pH falls as intracellular protons move into the extracellular 
compartment via the Na+/H+ exchanger, Na+/HCO3- co-transporter, lactate transport 
and lactic acid and CO2 diffusion. This results in intracellular and extracellular 
acidosis which if severe may result in complete cessation of anaerobic glycolysis. 
There are a number of possible sites within the cardiomyocyte at which H+ may have 
an effect as summarised in Figure 6-1. Initially, during the early stages of hypoxia 
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and anaerobic glycolysis, ATP levels are maintained by phosphocreatine breakdown 
due to the large capacity of the phosphocreatine pool, but ATP levels eventually 
become depleted, and adenine nucleotides may also be lost from the cell, which 
may compromise the cells recovery from anoxia. Certain rate-limiting glycolytic 
enzymes are inhibited by acidosis, and therefore the accumulation of intracellular 
H+ acts as a negative feedback mechanism to limit further acidification of the cell. 
Furthermore, the fall of ATP and the accumulation of ADP, Pi, and H+, results in 
inhibition of energy-dependent regulation of transmembrane ion gradients such as 
the Na+/K+ pump and sarcoplasmic reticulum Ca2+ cycling. Overall this results in a 
net accumulation of intracellular Na+ and Ca2+ in acidosis. Acidosis and membrane 
depolarisation associated with extracellular K+ accumulation slows conduction and 
these changes act both as a protective mechanism (174) and also contribute to the 
substrate for re-entry  
 
Figure 6-1 – Possible sites of action of H+ in the cardiomyocyte. 1 – ion channels and currents; 
2a – sarcolemmal bound Ca 2+; 2b – Na+/Ca2+ exchanger; 2c – Na+/H+ exchanger; 2d – Na+-K+ 
ATPase; 2e – Ca2+ ATPase; 3a – SR Ca2+ uptake; 3b – SR Ca2+ release; 4 – cytoplasmic Ca 2+ 
during acidosis; 5 – contractile proteins; 6 – cell metabolism and mitochondrial function. 
(Adapted from (170)).  
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6.1.3  Slowed conduction velocity in ischaemia and acidosis 
Conduction velocity slows in ischaemia by two mechanisms, namely by a decrease in 
the inward sodium current and also by cellular electrical uncoupling (172;173). The 
latter occurs as a consequence of the intracellular acidosis that occurs during 
ischaemia, increasing the resistance of gap junctions, which are composed of 
connexins. Connexins provide aqueous conduits between cells for current flow. Gap 
junctional conductance is decreased in response to increased H+, Ca2+ and decreased 
ATP with resultant slowing of the longitudinal spread of current through cardiac 
tissue (175). This is not purely a consequence of hypoxia, however, as demonstrated 
by Turin and Warner (176). They observed that when embryonic cells of Xenopus 
were exposed to 100% CO2 the intracellular pH was reduced from 7.7 to 6.4, the 
resting potential was decreased, the electrical coupling of the cells was abolished 
and the input resistance was increased. Similar results were found using mixtures of 
40%CO2/60% O2, suggesting the uncoupling is not purely due to hypoxia but at least 
partly due to a fall in pH. 
6.1.4 Effect of acidosis on the action potential and excitation-
contraction coupling 
Acidosis inhibits excitation-contraction coupling by a number of mechanisms (177-
180), namely inhibition of ICa,L, inhibition of the ryanodine receptor, inhibition of 
the sarcoplasmic reticulum calcium ATPase, reduction in amplitude of Ito and  
increase of the IKss and inwardly rectifying Cl- currents. Because of regional 
differences in the expression of ion channels underlying membrane currents, the 
effect of acidosis on the action potential will not be the same in all regions of the 
heart. In isolated rat atrial cells, reducing the pH of the bathing solution from 7.4 to 
6.5 resulted in shortening of the action potential, increased the inward current at –
80mV and depolarised the resting membrane potential (179). They concluded that 
an acidosis-induced increase in the steady state outward K+ current underlies the 
shortening of the action potential and an increase in the inwardly rectifying Cl- 
current underlies the depolarisation of the resting membrane potential. In rat 
ventricular myocytes, isolated from both epi- and endocardium, acidosis resulted in 
prolongation of the APD50 and depolarisation of the resting membrane potential. 
Before acidosis, there was heterogeneity of the APD between epi- and endocardial 
cells, with APD shorter in epicardial myocytes.The response to acidosis was also 
heterogeneous. Furthermore, the degree of prolongation of the APD in acidosis was 
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greater in endocardial cells than in epicardial cells (Figure 6-2) (178). This 
heterogeneity of the effect of acidosis on the action potential in different regions of 
the heart, including the dispersion of effect across the transmural surface of the 
ventricle, may further contribute to the substrate for conduction abnormalities and 
arrhythmias.  
 
Figure 6-2 – Action potential of epicardial (A) and endocardial (B) rat ventricular myocytes at 
control pH and during acidosis. (Adapted from (178)).  
 
6.1.5 Effect of acidosis on the ECG 
To further study the heterogeneity of the effect of acidosis on cardiac cells, Aberra 
et al (181) investigated the effect of acidosis on the ECG of the isolated rat heart. 
Perfusion with acidotic solution (pH 6.5) markedly slowed the heart rate and 
prolonged the PR interval of the ECG of the isolated rat heart (Figure 6-3). The 
effect of acidosis was rapid and reversible. There was no apparent effect on the 
duration of the QRS complex. The absence of any effect of acidosis on the duration 
of the QRS complex suggests that the prolongation of the PR interval was a 
consequence of conduction slowing through the AV node.  
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Figure 6-3 – Effect of acidosis on heart rate (top panel) and on PR interval and QRS duration 
(bottom panel). The horizontal bar denotes perfusion with solution at pH 6.5. (Adapted from 
(181)).  
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To date, no literature has been published on the response of isolated AV nodal 
tissue or AV nodal cells to acidosis. The present study was designed to investigate 
the effect of acidosis on the electrophysiology of the SA and AV nodes, determined 
by surface electrogram recordings from an isolated AV node tissue preparation. 
6.2 Methods 
Under terminal anaesthesia with sodium pentobarbitone 200mg/kg (Rhone Merieux) 
mixed with 500IU of heparin, hearts from adult male New Zealand White rabbits 
were rapidly excised and placed in ice cold Tyrode’s solution, of the following 
composition (mmol/L): Na+ 134.5, Mg2+ 1.0, K+ 5.0, Ca2+ 1.9, Cl- 101.8, SO4 1.0, 
H2PO4 0.7, Hepes 20, acetate 20 and glucose 50. The pH of aliquots of the solution 
was adjusted to 7.4, 6.8 and 6.3 by the addition of NaOH and HCl. Final solutions 
were oxygenated with 100% O2. The isolated AV node preparation was created as 
outlined in Chapter 2. This tissue was pinned onto a Sylgard plate and superfused 
with oxygenated Tyrode’s solution at pH 7.4. A constant superfusion rate of 
40ml/min was maintained using a Gilson Minipuls 3 peristaltic pump. Temperature 
was maintained at 37ºC. Baseline data was obtained at pH 7.4. The preparation was 
then superfused with solution at pH 6.8 and data recorded after 10 minutes. 
Following this, the preparation was superfused with solution at pH 6.3 and again 
data recorded after 10 minutes. To determine reversibility of the effects of 
acidosis, the solution was returned to pH 7.4 and data recorded after 10 minutes.  
6.2.1 Surface electrogram recording 
Electrograms recorded from the surface of the isolated atrioventricular node 
preparation were recorded using locally developed ECG acquisition software (NMap, 
Dr FL Burton, University of Glasgow). The spontaneous sinus cycle length was 
recorded in every experiment. The basic stimulus cycle length was 300ms. Atrio-
Hisian (AH) intervals, Wenckebach cycle length, functional and effective refractory 
periods of the AV node and the atrial effective refractory periods were derived 
using standard pacing protocols as described earlier.  
6.2.2 Optical mapping of activation 
The pattern of activation through the right atrial/AV node preparation during 
normal pH and acid pH was studied in a further series of 3 controls using the optical 
mapping methodology described earlier (see chapter 2, General Methods). Hearts 
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excised under terminal anaesthesia were loaded with RH237 via the coronary 
circulation via Langendorff perfusion. Thereafter the isolated right atrial 
preparation was prepared as previously described and mounted in a custom made 
chamber to allow superfusion with Tyrode’s solution of the above composition at pH 
7.4. The preparation was paced using protocols previously described to derive AH 
intervals and WCL at pH 7.4, 6.8 and 6.3. Surface electrograms and optically 
derived action potentials were recorded simultaneously.  
6.2.3 Statistical analysis 
At pH 7.4, n=11. In some cases, acidosis resulted in conduction block at the level of 
the AV node, precluding derivation of the AH interval, FRP or ERP. More details are 
given in the results section. Results are expressed as mean ± standard error of the 
mean unless otherwise stated. Comparisons between two groups of data were made 
using a paired Student’s t-test. A two-tailed p-value of less than 0.05 was 
considered statistically significant. 
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6.3 Results 
6.3.1 Effect of acidosis on spontaneous sinus cycle length 
Figure 6-4 shows the effect of reducing the pH of the superfusate on the 
spontaneous sinus cycle length of the isolated atrioventricular node preparation. 
There is significant prolongation of the spontaneous sinus cycle length at pH 6.8 
compared to normal pH conditions (pH 7.4: 420.5 ± 24.5; pH 6.8: 572.7 ± 56.8, 
p<0.05). There was further significant prolongation of the spontaneous sinus cycle 
length at pH 6.3 (pH 6.8: 572.7 ± 56.8; pH 6.3: 720.2 ± 59.6, p<0.05). The effects of 
lowering pH on the spontaneous sinus cycle length were reversible at 10 minutes 
(pH 7.4 return: 493.7 ± 29.9). 
 
Figure 6-4 - Effect of pH on spontaneous sinus cycle length. Significant, reversible prolongation of 
the spontaneous sinus cycle length occurred in the presence of an acidic pH. *p<0.05. N=11 at all 
3 pHs.  
 
6.3.2 Effect of acidosis on AV node conduction characteristics 
There was significant, reversible prolongation of the WCL with reduction in pH 
(Figure 6-5). Furthermore, the AH intervals progressively prolonged with reduction 
in pH (Figures 6-6 and 6-7). Table 6-1 summarises the effects of acidosis on WCL and 
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AH intervals at PCL 300ms and 200ms. In 4 of 11 samples, complete heart block 
occurred at PCL 300ms in pH 6.3. In 9 of 11 samples complete heart block occurred 
at a PCL 200ms in pH 6.3, therefore these values were excluded from the analysis. 
However, figure 6-7 documents progressive prolongation of the AH interval at PCL 
200ms in pH 6.3 of the two samples which did conduct through the AV node at this 
pH.   
 pH 7.4 pH 6.8 pH 6.3 pH 7.4 return 
WCL 198.2 ± 21.5 268.3 ± 29.4 296.0 ± 46.8 262.0 ± 32.8 
AH300 45.8 ± 3.1 54.2 ± 3.5 68.5 ± 7.4 68.5 ± 7.4 
AH200 76.0 ± 26.2 90.9 ± 24.6 - 85.3 ± 24.2 
Table 6-1- Effect of pH on AV node conduction characteristics. WCL - Wenckebach cycle length; 
AH300 - AH interval at PCL 300ms; AH200 - AH interval at PCL 200ms. N=11 except at pH 6.3 (PCL 
300ms) where N=7 and at pH 6.3 (PCL 200ms) where N=2.  
 
Figure 6-5- Effect of pH on Wenckebach cycle length. Significant, reversible prolongation of the 
WCL occurred in the presence of an acidic pH. *p<0.05; ***p<0.001. 
Ashley M. Nisbet, 2008  Chapter 6; 141 
 
Figure 6-6 - Effect of pH on AH interval at PCL 300ms. *p<0.05; **p<0.01. 
 
Figure 6-7 - Effect of pH on AH interval at PCL 200ms. In 9 of 11 samples, complete heart block 
occurred at pH 6.3 therefore were excluded from analysis. In two samples, as shown in blue, 
conduction through the AV node persisted despite pH 6.3. *p<0.05; *p<0.01. 
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6.3.3 Effect of acidosis on refractory characteristics of the atrium 
and AV node 
Progressive prolongation of the AV nodal functional and effective refractory periods 
occurred in the presence of acidosis. Refractory periods were derived at PCL of 
300ms. Figure 6-8 shows examples of the AV nodal refractory curves derived from 
one sample, demonstrating the effect of acidosis, namely upward shift in the curves 
due to an increase in the ERP and FRP with reduction in pH. This effect was 
consistent throughout all experiments.The cumulative results are expressed as mean 
± SEM. H1H2 values for each A1A2 shown in figure 6-9. At pH 6.3, in all but three 
samples premature stimulation, decrementing from PCL 300ms to only 295ms, 
resulted in conduction block immediately such that it was not possible to derive the 
FRP or ERP. These samples were therefore excluded from the analysis. In samples 
with persistent conduction allowing FRP and ERP to be derived, the FRP and ERP 
further prolonged at pH 6.3 compared to pH 6.8, as shown in figures 6-11 and 6-13. 
Table 6-2 documents the effect of pH on atrial and AV nodal refractory 
characteristics. 
 pH 7.4 pH 6.8 pH 6.3 pH 7.4 return 
AVN FRP 205.1±21.7 237.6±18.4 220.7±27.4 246.3±33.4 
AVN ERP 176.8±22.0 210.7±16.9 209.3±30.6 220.4±27.7 
Atrial ERP 120±22.3 153.3±19.3 187.5±27.7 139.2±14.8 
Table 7-2 - Effect of pH on atrial and AV nodal refractory characteristics. AVNFRP - AV nodal 
functional refractory period; ERP - effective refractory period. N=11 except at pH 6.3 where N=3.  
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Figure 6-8 - Effect of pH on AV node refractory curve. 
 
Figure 6-9 - Effect of pH on AV node refractory curves - cumulative (mean) results. 
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Figure 6-10 - Effect of pH on AVN FRP. FRP determined at a basic PCL of 300ms. This figure shows 
the overall mean changes in FRP. At pH 7.4 and 6.8, n=11. At pH 6.3, n=3 due to conduction 
block in the remainder. 
 
Figure 6-11 - Effect of pH on AVN FRP. In blue, the three samples in which FRP could be 
determined at pH 6.3. This confirms that the FRP further prolongs at pH 6.3 compared to pH 6.8. 
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Figure 6-12 - Effect of pH on AVN ERP. ERP determined at basic PCL of 300ms. This figure shows 
the overall mean changes in AVN ERP. At pH 7.4 and 6.8, n=11. At pH 6.3, n=3 due to conduction 
block in the remainder. 
 
Figure 6-13 - Effect of pH on AVN ERP. In blue, the three samples in ERP could be determined at 
pH 6.3. This confirms that the ERP further prolongs at pH 6.3 compared to pH 6.8. 
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6.3.4 Effect of acidosis on optically derived activation times 
Typical optically derived action potentials are shown in Figure 6-14. Figures 6-15A 
and 6-16A illustrate the effect of pH on activation time of the optically derived 
action potential (Tact) during both spontaneous activation and right atrial pacing. On 
decreasing the pH from 7.4 to 6.3, there is a consistent increase in the activation 
time most marked at the compact node and His bundle regions (ANOVA P<0.001). 
The effect is less pronounced at the atrial and AVN input regions. The conduction 
times between regions (? Tact) are shown in figures 6-15B and 6-16B, where 1 = 
conduction time between the atrium and the AVN input, 2 = conduction time 
between the AVN input and the compact node and 3 = conduction time between the 
compact node and the His bundle. There is considerable slowing of the impulse 
conduction at region 2 (AVN input to compact AVN) with reducing pH from 7.4 to 6.8 
and 6.3. Statistical significance was not reached due to the small sample size (n=3). 
During right atrial pacing at PCL 250ms, at pH 6.3 there was no conduction of the 
atrial impulse in 2 of 3 samples, therefore data for pH 6.3 are not shown in Figure 6-
16B.  
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Figure 6-14 – A – Activation time (Tact, mean ± SEM ms) at designated regions at pH 7.4, 6.8 and 
6.3. B – Change in activation time (?Tact, mean ± SEM ms) between regions (1=atrial to AVN 
input; 2=AVN input to compact node; 3=compact node to His bundle). N=3 at each pH. 
Preparations unpaced.  
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Figure 6-15 - A – Activation time (Tact, mean ± SEM ms) at designated regions at pH 7.4, 6.8 and 
6.3. B – Change in activation time (?Tact, mean ± SEM ms) between regions (1=atrial to AVN 
input; 2=AVN input to compact node; 3=compact node to His bundle). N=3 at pH 7.4 and 6.8 but 
n=1 at pH 6.3 due to failure of conduction of the atrial impulse in 2 preparations. Preparations 
paced at cycle length 250ms. .  
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Figure 6-16 – Isochronal maps of activation showing conduction delay with reducing pH. Region 
1 = atrial to proximal AVN; 2 = proximal to compact nodal AVN; 3 = compact AVN to His bundle. 
The key on the right is in milliseconds. Activation times are relative to the onset of the atrial 
electrogram.  
 
Figure 6-17 shows isochronal maps of activation derived from the optically derived 
action potentials at pH 7.4, 6.8 and 6.3. Measurements are in milliseconds relative 
to the onset of the atrial action potential. At every pH there is an area of 
conduction delay between the proximal and compact AV node (Region 2). The 
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magnitude of delay is increased with reducing pH. In the above example there is 
also evidence of conduction delay between the atrial stimulus and the proximal AV 
node (region 1) at pH 6.3 that is not apparent at pH 6.8 or 7.4. It is also interesting 
to observe that in region 2, corresponding to the area surrounding the coronary 
sinus, there is an increase in conduction time along the floor of the coronary sinus 
compared to the superior aspect of this region. This area is anatomically and 
functionally considered the “slow pathway” of the AV node and these results 
confirm dual pathway AV nodal conduction in this sample. Furthermore, the 
magnitude of conduction delay occurring at pH 6.8 in region 2 is much greater at 
the area corresponding to the slow pathway than superiorly.  
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6.4 Discussion 
The present study confirms that in an isolated AV node preparation, acidosis has 
significant effects on the electrical activity of the sinoatrial node and on the 
conduction and refractory characteristics of the AV node. The results and possible 
mechanisms are discussed in detail below.  
 
6.4.1 Physiological significance of experimental conditions 
Assuming an extracellular pH (pHo) of 7.4, the intracellular pH (pH i) of most cell 
types is maintained between 6.8 and 7.2. Myocardial ischaemia is characterised by 
hypoxia, hyperkalaemia and profound acidosis in the extracellular space. 
Consequently, pH i is also markedly reduced in ischaemia, with reductions of 0.5 pH 
units being observed in some studies (170). The presence of modest acidosis (pH 
6.8) has previously been associated with changes in the electrophysiological 
characteristics of sinoatrial nodal cells (182). Furthermore, reducing the pH of the 
perfusate to pH 6.5 has also been shown to both slow the heart rate and prolong the 
PR interval in isolated rat hearts (181). In myocardial ischaemia, values of pH i as low 
as 6.2 have been recorded (183). In studies measuring the pH i using the fluorescent 
dye 2’,7’-bis(2-carboxyethyl) -5(6)-carboxyfluorescein, the pH i decreases by 
approximately 0.5 pH units in response to a reduction in the pHo from 7.4 to 6.5 
(184). The pH i reaches steady state within 3 minutes (170). The present study 
investigates the effect of both modest and severe acidosis using superfusate at pH 
6.8 and 6.3. These values are within the range observed pathophysiologically. Data 
were acquired at 10 minutes after each exchange of solution, allowing adequate 
time for washout of the previous solution and time for the effects of the acid 
solution to reach steady state.  
 
6.4.2 Effect of acidosis on sinus node automaticity 
Reducing the pH of the superfusate from pH 7.4 to 6.8 caused a significant 
reduction in the spontaneous sinus rate, an effect which was enhanced by reducing 
the pH further to 6.3. This result is in keeping with observations made by other 
groups. Acidosis has previously been reported to alter the rate of contraction of 
isolated atria, whether induced by HCl (mimicking metabolic acidosis) or CO2 
(mimicking respiratory acidosis) (185). Furthermore, Aberra et al observed 
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significant reduction in heart rate in isolated Langendorff perfused rat hearts in the 
presence of acidic pH (181).  
 
The mechanism whereby acidosis inhibits the sinus node is unclear. Aberra et al 
hypothesised that the inhibition of the sinus node in acidosis was mediated by an 
increase in Ito, in keeping with observations that in ventricular myocytes Ito becomes 
larger in acidosis and when the diastolic membrane potential is depolarised (186). 
However, in the isolated rat heart, blocking Ito by adding 4-Aminopyridine (4-AP) 
had no effect on the changes in heart rate observed in the presence of acidosis 
(181), making Ito mediated inhibition of the sinus node unlikely. 
Inhibition of heart rate in the presence of acidosis may be a consequence of 
alteration in the pacemaker currents in the sinus node. The SA node contains 
specialised cells that generate action potentials that are different to ventricular 
myocyte action potentials (187). Sinoatrial nodal cells do not have a true resting 
membrane potential. Action potentials are characterised by the presence of a 
“pacemaker potential”, which is a slow diastolic depolarisation phase (Phase 4) of 
the action potential. This renders these cells spontaneously active. Heart rate is 
determined by the rate of action potential firing, which is determined by the slope 
of the phase 4 depolarisation (188). The generation and control of the diastolic 
depolarisation in SAN cells is predominantly due to the pacemaker “funny” current, 
If, first described in detail in 1979 (189). Typical features of this current include 
hyperpolarisation-induced activation, slow kinetics of activation and deactivation, 
mixed Na+ and K+ ionic permeability, and modulation by cAMP (190). Inhibition of If 
occurs in the presence of acetylcholine, suggesting that autonomic modulation of 
heart rate is If mediated. However, Aberra et al excluded the possibility that 
reduction in sinus rate in acidosis was due to acidosis-induced changes in 
neurotransmitter release from severed autonomic nerve terminals within the heart, 
because the changes persisted in the presence of antagonists atropine and 
propranolol (181). Extrapolating this observation to the present study, slowing of 
the sinus rate in the presence of acidosis is not due to muscarinic modulation of If, 
but may be due to direct inhibition of If. Further study into the effect of acidosis on 
the pacemaker potential of isolated SAN cells is required to clarify the mechanism. 
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6.4.3 Effect of acidosis on parameters of AV nodal function 
6.4.3.1 Effect of acidosis on conduction time (AH interval and WCL) 
In the present study, we observed significant prolongation of the AV conduction 
time with reduction of the pH of the superfusate. This was manifest by significant 
prolongation of the AH intervals at baseline and at all pacing cycle lengths. The AH 
intervals shifted to the right in the presence of acidosis. The pacing rate at which 
AV nodal block was observed (Wenckebach phenomenon) was significantly slower at 
pH 6.8 than at 7.4, and yet slower at pH 6.3. In the presence of severe acidosis, 
profound AV nodal block was observed, most marked at faster pacing rates. In 4 of 
11 samples, complete AV block occurred at PCL 300ms at pH 6.3. In 9 of 11 samples 
complete AV block occurred at a PCL 200ms at pH 6.3. The effect of acidosis on AH 
interval and Wenckebach cycle length appear to be partially reversible at 10 
minutes of washout with superfusate at pH 7.4. Further confirmation was gained 
from the optical mapping experiments, in which slowing of conduction between the 
AVN inputs and the compact node appeared to be the major contributor to the 
acidosis induced prolongation of the AH interval. Furthermore, conduction block as 
proximal as the inputs of the AV node at pH 6.3 during right atrial pacing limited the 
analysis of 2 of 3 samples studied.  
 
Aberra et al observed prolongation of the PR interval with no change in the QRS 
duration in the ECG of the rat heart in the presence of acidosis (181). They 
postulated that the absence of effect of acidosis on the QRS duration suggested that 
the prolonged AV delay was due to conduction delay at the level of the AV node 
with no effect on intra-ventricular conduction. The results of the present study are 
in keeping with this hypothesis. However, in the isolated AV node preparation the 
ventricular tissue is removed therefore it is not possible to extrapolate the results 
to comment on the effect of acidosis on intra-ventricular conduction.  
 
The mechanism whereby acidosis prolongs conduction through AV nodal tissue was 
not explored in the present study. Heterogeneity of ion channel and gap junction 
expression exists within the AV nodal architecture (46;47). Transitional cells of the 
AV node (AN and NH cells) have relatively abundant sodium current (INa). There is a 
relative lack of expression of sodium channels in the ovoid type compact nodal cells 
(N cells), in which the main depolarising current is the L-type calcium current (ICa,L). 
This results in a relatively slow Phase 0 and therefore a slow speed of conduction. 
Acidosis has been shown to inhibit ICa,L in rat ventricular myocytes (180). Inhibition 
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of ICa,L by acidosis in AV nodal cells would slow the speed of the upstroke of the 
action potential and subsequently slow conduction. The main repolarising currents 
of the AV node are the transient outward K+ current (Ito) and the delayed rectifier K+ 
current (IKr). Aberra et al explored the possibility of inhibition of Ito, by the addition 
of 4-AP to the perfusion fluid (181). Similar to their observations on the effects on 
heart rate, 4-AP did not alter the effects of acidosis on PR interval. It is therefore 
unlikely that Ito is implicated in the observed AV nodal delay in acidosis.    
 
Acidosis increases gap junctional resistance, which slows the transmission of action 
potentials from cell to cell (175). This is likely to be a significant contributor to the 
observed conduction delay in the AV node in the presence of acidosis.  
 
6.4.3.2 Effect of acidosis on atrial and AV nodal refractory characteristics 
In addition to the observed prolongation of AV nodal conduction, acidosis alters the 
refractory characteristics of the atrium and AV node in this preparation. There was 
significant prolongation of both the effective and functional refractory period of the 
AV node at pH 6.8 compared to pH 7.4. This resulted in upward shift of the 
refractory curves at pH 6.8, and further upward shift at pH 6.3. However, due to 
conduction block, it was only possible to generate refractory curves in 3 samples at 
pH 6.3. However, despite this, the overall effect of further prolongation of the ERP 
and FRP in the presence of severe acidosis (as compared to moderate acidosis) is 
confirmed as shown in Figures 6-11 and 6-13. It is interesting to note that in 
contrast to measures of conduction delay, the effect of acidosis on AV nodal 
refractoriness do not appear to reverse at 10 minutes of washout with superfusate 
at pH 7.4. 
Atrial effective refractory period is also significantly prolonged by acidosis. The 
magnitude of the effect is inversely proportional to the pH of the superfusate. The 
effect appears to be reversible. 
AV nodal refractory periods represent a composite of the effective refractory 
periods of a number of different cell types within the heterogeneous structure that 
is the AV node. There is evidence that different cell types (from different regions) 
within AV nodal tissue contribute to a varying extent to nodal refractoriness (49). 
This may yield some clues to the mechanisms by which acidosis exerts its effects on 
AV nodal function. The functional refractory period of the AV node is by definition 
the minimum H1H2 that can be propagated to the ventricle from the atria, and as 
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such is an important determinant of the ventricular response to fast atrial rates. 
When heart rate increases, a change in the conduction time of the regular beats 
causes a decrease in the functional refractory period (56). Thus it can be deduced 
that the increase in the functional refractory period of the AV node in response to 
acidosis is a function of the increase in conduction time through the AV node at the 
predefined pacing cycle lengths. The effective refractory period of the AV node may 
also to some extent be influenced by conduction time, but is more importantly 
influenced by the longest ERP of the components of the conduction pathway (58). 
Workman et al postulated that mid-nodal cells may have the greatest influence on 
the ERP of the intact AV node based on observations that the mid-nodal cells had a 
longer ERP compared to cells from the proximal, transitional nodal region (59). 
Furthermore, Workman et al showed that Ito does not contribute to ERP in isolated 
AV nodal cells (58). This is in keeping with the hypothesis that the observed changes 
in AV nodal conduction time are not due to changes in Ito in response to acidosis. It 
follows therefore that prolonged ERP (and FRP) is not due to inhibition of Ito in 
acidosis. The kinetics of ICa,L may account for both conduction slowing and prolonged 
ERP of the AV node in this preparation. 
 
6.4.4 Conclusion 
This study has shown that significant prolongation of AV nodal conduction time 
occurs in the presence of acidosis, as evidenced by prolongation of the AH interval 
and Wenckebach cycle length, proportional to the severity of acidosis. This confirms 
that the origin of prolongation of the PR interval of the ECG in the presence of 
acidosis is due to intrinsic conduction delay at the level of the AV node. The optical 
mapping data have indicated that conduction delay between the AV nodal inputs 
and the compact AV node regions is the major contributor to prolongation of the AH 
interval, which translates as prolongation of the PR interval of the surface ECG. This 
study has also demonstrated prolongation of AV nodal functional and effective 
refractory periods in the presence of acidosis. The mechanisms underlying these 
observations are likely to be complex and multiple. It is likely that acidosis induced 
inhibition of ICa,L plays a role in both conduction delay and prolongation of the ERP. 
In addition, the effect of acidosis on the electrotonic interaction between AV nodal 
cells is a likely contributor. Further investigation is ongoing into the effect of 
acidosis on the ion currents in isolated AV nodal cells to clarify the mechanisms 
involved.  
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Chapter 7 - Synopsis 
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7 Synopsis 
7.1 Summary of aims and key findings 
The main aim of this thesis was to confirm the presence of abnormal conduction 
delay at the level of the AV node in the rabbit model of LVD due to apical 
myocardial infarction. Further investigations aimed to determine the spatiotemporal 
pattern of the delay within the AV node and then to determine the underlying 
mechanism. These investigations were carried out on an isolated tissue preparation 
comprising right atrial and AV nodal tissue using a combination of surface 
electrogram recordings and optical mapping of electrical activation using voltage 
sensitive dye. The key findings of the investigations were: 
1. There is abnormal prolongation of AV delay in the rabbit model of LVD due to 
apical myocardial infarction, confirmed by prolongation of the AH interval and 
Wenckebach cycle length in LVD preparations compared to control animals.  
2. The prolongation of the AH interval is predominantly a consequence of 
conduction delay between the AV nodal input and the compact nodal regions of the 
preparation. 
3. There was no evidence of ß-adrenoceptor downregulation in the AV node in LVD 
compared to control to account for the abnormal conduction delay. 
4. There was no evidence of an increase in the action of endogenous adenosine in 
the AV node of LVD animals, but there was an increased sensitivity to exogenous 
adenosine in these samples, and  
5. Acidosis caused similar prolongation of AV nodal delay with a similar 
spatiotemporal pattern to the effects observed in LVD.  
These findings are summarised in detail below.  
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7.1.1 Abnormal AV nodal conduction delay in the rabbit model of 
LVD due to apical myocardial infarction 
Previous research has suggested that there may be abnormal AV nodal conduction 
delay in the rabbit model of LVD due to apical myocardial infarction despite 
absence of any direct ischaemic insult to the base of the heart (81). This thesis has 
confirmed that the observed AV delay in the whole heart model studied by NL 
Walker is due to delay originating in AV nodal tissue. At both 8 and 32 weeks post 
coronary ligation, LVD animals exhibited significant prolongation of AH interval and 
Wenckebach cycle length compared to controls. The overall AV nodal recovery curve 
was shifted upwards and to the right in LVD at 8 weeks and further at 32 weeks post 
infarct. This was in the absence of any significant increase in AV nodal refractory 
periods at 8 weeks, but a modest increase in AV nodal FRP at 32 weeks. Sinus node 
automaticity was not affected.  
7.1.2 Spatiotemporal pattern of AV nodal delay 
Using optical mapping of electrical activation, I was able to confirm that the 
prolongation of AH interval occurred as a consequence of abnormally delayed 
conduction between the AV nodal inputs and the His bundle region. There was an 
almost 4-fold increase in the mean conduction time between the AV nodal inputs 
and the compact node and a 3-fold increase in mean conduction time between the 
compact AV node and the His bundle region in LVD compared to controls (Figure 3-
13). A characteristic of the LVD model used is an increase in the left atrial diameter 
(Table 2-1). I ensured that the distance between the electrodes recording the 
surface electrograms from the isolated AV node preparation was consistent during 
optical mapping experiments to exclude left atrial enlargement as a contributor to 
the observed increase in AH interval. Furthermore, on optical imaging there was no 
evidence of delayed conduction through atrial myocardium, strengthening the 
conclusion that the delay is due to remodelling of AV nodal conduction.  
7.1.3 Mechanism of prolonged AV nodal delay in LVD 
Four theoretical mechanisms were identified and investigated as potential causes of 
the abnormal AV nodal conduction delay observed in LVD. These are outlined below: 
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7.1.3.1 Age-related degenerative changes in AV nodal conduction 
Age-related AV nodal conduction disturbances are recognised to occur frequently in 
human (111-113) and animal studies (115;132). Although not statistically significant, 
there appeared to be progressive prolongation of AH intervals and further increase 
in Wenckebach cycle length at 32 weeks compared to 8 weeks post infarct. To 
investigate the possibility that there is an age related phenomenon rather than 
progression of the effect of the LVD condition a series of sham operated animals 
were studied at 32 weeks post sham ligation procedure to age match for the 32 
week LVD samples. There was evidence of modest but not statistically significant 
prolongation of the AH intervals and significant prolongation of WCL in the 32 week 
sham operated animals compared to younger controls (aged 12-20 weeks). AV nodal 
refractory periods were not affected by age in this study. When the 32 week sham 
operated animals were compared to the 32 week infarct, the magnitude of the 
increase in AH interval was much less marked in the sham compared to the infarct 
group. Overall, one may conclude that age may indeed contribute to the progressive 
prolongation of AV nodal delay in the LVD model but age cannot be considered to be 
a major factor resulting in this phenomenon.  
7.1.3.2 Beta-adrenergic sensitivity of the AV node in the rabbit model of LVD 
The negative inotropic effect of chronic catecholamine excess and subsequent ß-
adrenoceptor downregulation in the left ventricle has been demonstrated in both 
human (74-76) and animal studies (77-79). This pathophysiological phenomenon is 
the target of prognostically beneficial ß-blocker therapy in chronic heart failure in 
humans (191-194). I postulated that global ß-adrenoceptor downregulation may 
occur in the failing heart resulting in a negative dromotropic effect through the AV 
node in LVD. This did not appear to be the case, with no difference observed in the 
EC50 for isoproterenol between control and LVD samples (Table 4-1). In contrast to 
expected findings, there was an increase in the maximal reduction of the AH 
interval and WCL in LVD compared to controls, suggesting enhanced effect of 
isoproterenol in LVD in the AV node of LVD samples compared to controls. This “up-
regulation” of AV nodal ß-adrenoceptors may have a protective role to play, helping 
to prevent high degree AV block in vivo, which is known to be associated with a 
poorer prognosis in chronic heart failure. 
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7.1.3.3 Endogenous and exogenous adenosine and AV nodal delay in LVD  
In the absence of evidence of chronic ß-adrenoceptor downregulation as a 
mechanism underlying the abnormal prolongation of AV nodal delay, I looked to 
another neuro-humoral factor known to have profound effects on AV nodal 
conduction: adenosine. I postulated that tonic depression of AV nodal conduction 
may occur in LVD, which appeared to be overcome by ß-adrenergic stimulation, for 
example as a result of excess endogenous adenosine production. In a series of 
experiments examining the differential effects of exogenously applied adenosine A1 
receptor antagonist (CPX) there was no evidence of an excess of endogenous 
adenosine in the isolated AV node preparations from LVD samples compared to 
controls (Figures 5-1 – 5-3).  
In contrast, there was a marked increase in the sensitivity of the LVD samples to 
exogenous adenosine compared to controls, with a significant increase in the AH 
interval and WCL with increasing adenosine concentrations (Figure 5-4). The effects 
of exogenous adenosine were reversible with CPX in both controls and LVD. This 
increased sensitivity to adenosine in LVD may potentially be protective to the 
impaired ventricle from the increased oxygen demand that ensues from rapid atrial 
rates, as may be caused by atrial fibrillation, which occurs in up to 50% of 
individuals with chronic heart failure (195;196). However, it may also be 
detrimental to the already failing heart as adenosine released in response to a 
hypoxic insult may have a direct effect on conduction at the level of the AV node, 
resulting in degrees of AV block that further impair cardiac function.  
7.1.3.4 Slowed AV nodal conduction as a consequence of changes in gap 
junction expression/conductance 
In this thesis, functional studies of AV nodal conduction in LVD have shown 
significant conduction delay originating within the AV node, extending to the His 
bundle region, with little effect on AV nodal refractory periods. This indicates a 
disturbance of the electrotonic interaction of cells comprising the AV junction as a 
mechanism underlying the delay. There is considerable diversity in connexin 
expression patterns within the architecture of the AV junction, which is thought to 
be relevant to its complex conduction characteristics (197;198). Studies of connexin 
40 deficient mice have shown evidence of abnormal AV nodal conduction (199;200). 
As part of this investigation AV node preparation samples were sent to colleagues in 
the University of Oxford with expertise in the histological analysis and 
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immunohistochemistry of the AV junction. The preliminary results are summarised 
in Appendix 1. Control data was acquired from 2 samples, 8 week infarct data from 
1 sample and 32 week infarct data from 2 samples. The key findings from this 
preliminary analysis are: 
(i). Within the AV node, there is a statistically significant increase in the area of Cx 
40 expressed by myocytes and fibroblasts at 8 weeks post infarct compared to 
control (Table 2). This effect is not seen at 32 weeks in the samples analysed thus 
far.  
(ii). At the fibroblast rich interface between the AV node and the ventricle 
(understood to be anatomically consistent with the His bundle region) there is a 
reduction in Cx 43 and an increase in the density of Cx 40 expression by fibroblasts 
at 8 and 32 weeks post infarct (Table 3).  
This relative abundance of Cx40 within the AV node and the His bundle region in the 
LVD samples may account for the reduction in conduction velocity observed.  
Overall the distribution of gap junctions within the AV node is unchanged in the LVD 
samples compared to control. Further work is ongoing with additional samples. It 
remains unclear if these changes in connexin expression, although statistically 
significant, are of a magnitude sufficient to see functional changes in AV nodal 
conduction. It does appear, however, that AV nodal conduction delay in LVD may be 
caused at least in part by disturbance in the electrotonic interactions between cells 
at the AV junction. 
7.1.4 Acidosis slows sinus node automaticity and AV nodal 
conduction 
Myocardial hypoperfusion can result in global myocardial acidosis. Regional 
hypoperfusion, for example as a result of coronary arterial occlusion, reduces extra-
cellular and intra-cellular pH and has a negatively inotropic and potentially 
arrhythmogenic effect on the myocardium (170;171). Previous investigators have 
demonstrated evidence of reduced sinus node firing rate and prolonged AV 
conduction in whole hearts subjected to acidosis (181). I investigated the effects of 
acidosis on atrial-AV nodal conduction. I demonstrated significant prolongation of 
the spontaneous sinus cycle length, AH interval, WCL and AV nodal FRP and ERP 
proportional to the degree of acidosis in the isolated rabbit AV node preparation 
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(Figures 6-4 – 6-13). These effects were reversible. Optical mapping studies showed 
that the spatiotemporal pattern of AV delay during acidosis was similar to that 
observed in LVD samples, with the predominant delay in conduction occurring 
between the AV nodal input and the compact AV node (Figures 6-15 – 6-16).  
The acute, reversible changes in AV nodal conduction characteristics during acidosis 
point to changes in ion channel function/kinetics rather than changes in gap 
junctional expression at the AV junction, although gap junctional conductance is 
likely to be reduced. I hypothesised that acidosis alters the kinetics of ICa,L, INa and 
IK,r, as well as reduced cell-cell coupling, resulting in conduction slowing and 
prolongation of refractory periods of the AV node in this preparation. Appendix 2 
shows the results of preliminary mathematical modelling studies carried out Drs 
Boyett and Inada in the University of Manchester. To simulate the effect of acidosis, 
they reduced the L-type Ca2+ current (ICa,L), rapid delayed K+ current (IK,r), Na+ 
current (INa) and cell-to-cell coupling (gj). Assuming that acidosis reduced L-type 
Ca2+ current, rapid delayed outward K+ current, Na+ current and cell-to-cell 
communication (i.e. the coupling conductance, gj), they investigated these changes 
in the string model. The simulation results showed a prolongation of the effective 
refractory period and functional refractory period as well as increase in the AV node 
conduction time. These results are comparable to experimental results. Further 
work is ongoing to investigate the effects of acidosis in isolated atrial and AV nodal 
cells and confirm the results of the current experiments and mathematical 
modelling studies.  
7.2 Clinical relevance and conclusion 
Conduction abnormalities are common in chronic heart failure and are associated 
with an adverse prognosis. The resultant detrimental effect on LV haemodynamics is 
the target of cardiac resynchronisation therapy, which aims to optimise ventricular 
preload by shortening AV delay to minimise pre-systolic mitral regurgitation, and 
resynchronise right and left ventricular activation/relaxation sequence.  
This thesis has confirmed that even in the absence of direct ischaemia to the AV 
junction, conduction abnormalities may occur as a pathophysiological response to a 
myocardial infarction resulting in left ventricular dysfunction. The mechanisms 
underlying this response are likely to be complex and multiple, and are not yet 
clear. In the acute setting, hypoxia resulting in regional and/or global myocardial 
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acidosis results in conduction delay as a consequence of reduced ion channel 
conductance as well as slowed conduction through disturbance of cell-cell coupling. 
This appears to be reversible in the short term, however the longer term effects are 
not clear. It may be that chronic hypoperfusion, hypoxia and lactic acidosis due to 
tissue hypoperfusion as a consequence of the infarction result in irreversible global 
detrimental effects affecting both ventricular systolic function and the conducting 
system. While adaptive, and potentially protective responses may occur as 
demonstrated in this thesis (increase in the maximal reduction of the AH interval in 
response to beta-adrenergic stimulation in LVD, and increased sensitivity of the AV 
node to adenosine in LVD) these do not effectively reverse the global negative 
inotropic and negative dromotropic effect of ischaemic myocardial disease. Cardiac 
resynchronisation therapy effectively improves haemodynamics when the 
pathological state is established, however the aim remains the prompt restoration 
of myocardial oxygen supply to minimise the effects of the ischaemic insult. Further 
work is required to establish the electrophysiological basis for conduction 
abnormalities in CHF, which may lead to the development of targeted therapeutic 
strategies to improve symptom control and overall survival for patients.  
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Table 1 - Area of myocytes (M) and fibroblasts (F) in AVN, and Ventricle and Atrium surrounding the AVN. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data obtained at control and different post-infarction time points were compared using ANOVA. Data are presented as mean ± S.E.M. 
*P < 0.05 and **P < 0.001 vs. control (statistically significant differences) 
 Ventricle  Atrium  AVN 
 Control 
n=39 
8 weeks 
n=52 
32 weeks 
n=74 
 Control 
n=53 
8 weeks 
n=56 
32 weeks 
n=46 
 Control 
n=35 
8 weeks 
n=37 
32 weeks 
n=75 
% M Area 72.62±1.64 75.57±1.08 82.07±0.89**  67.39±1.36 76.08±1.12** 67.77±1.13  39.94±2.00 61.25±1.37** 34.47±1.00* 
% F Area 12.76±0.43 14.5±0.62 8.918±0.57**  13.33±0.5 20.54±0.68** 9.40±0.30**  22.65±1.04 25.96±0.92* 15.93±0.54** 
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Table 2 - Gap junction density (Cx43 and Cx40) in AVN, and Ventricle and Atrium surrounding the AVN. 
M= Area of gap junction expressed by myocytes (M) 
F= Area of gap junction expressed by fibroblasts (F) 
M/F = ratio of area of gap junction expressed by myocyte/ area of gap junction expressed by fibroblasts 
F/M = ratio of area of gap junction expressed by fibroblasts / area of gap junction expressed by myocyte  
% GJ on M= % of gap junctions expressed by myocytes 
% GJ on F= % of gap junctions expressed by fibroblasts 
% GJ on MF= % of gap junctions expressed by both myocytes and fibroblasts 
There is no Cx43 in AVN and Cx40 in Ventricle is only present in blood vessels. 
Data obtained at control and different post-infarction time points were compared using ANOVA. Gap junction density is expressed as area of connexin related fluorescence per 
cell type tissue area (?m2??m-2), and as the ratio of M/F or F/M. Data are presented as mean ± S.E.M. *P < 0.05 and **P < 0.001 vs. control (statistically significant differences).  
 Cx43  Cx40 
 Ventricle   Atrium  Atrium  AVN 
Control 
n=20 
8 weeks 
infarct 
n=29 
32 weeks 
infarct 
n=51 
 Control 
n=23 
8 week 
n=30 
32 weeks 
n=26 
 Control 
n=30 
8 weeks 
n=26 
32 weeks 
n=20 
 Control 
n=35 
8 weeks 
n=37 
32 weeks 
n=75 
M 2.50±0.23 3.00±0.24 2.94±0.16  1.73±0.14† 1.75±0.07†† 1.68±0.09††  10.61±0.84‡‡ 5.71±0.49**‡‡ 5.28±0.36**‡‡  18.92±1.53? ?  25.32±0.78**? ?  7.38±0.54** 
F 1.16±0.12 3.89±0.30** 1.36±0.08  0.58±0.07† 1.54±0.18**†† 0.72±0.06††  4.32±0.44‡‡ 2.12±0.18**‡ 3.60±0.33‡‡  4.05±0.57 7.38±0.40**? ?  1.47±0.07**? ?
M/F 2.19±0.11 0.77±0.02** 2.36±0.11  3.55±0.28† 1.45±0.11**†† 2.74±0.27*  2.65±0.09‡ 2.77±0.10‡‡ 1.78±0.21**‡  6.95±0.77? ?  3.67±0.16**? ?  5.44±0.34*? ?
A
re
a 
?1
0-
2  ?
m
2 ?
?m
 -2
  
F/M 0.48±0.03 1.33±0.04* 0.468±0.02  0.33±0.03† 0.87±0.09**†† 0.44±0.04  0.39±0.013 0.37±0.01‡‡ 0.71±0.07**‡  0.21±0.02? ?  0.286±0.01*? ?  0.261±0.02? ?
 GJ on M 95.8±0.5 90.7±0.46** 97.8±0.24*  95.4±0.46 93.7±0.75† 96.1±0.51†  96.6±0.4‡ 97.3±0.28‡ 95.3±0.47  98.1±0.18?  96.3±0.20**?  98.25±0.20? ?
% GJ on F 7.4±0.43 28.6±1.80** 4.55±0.25  7.20±0.62 19.3±1.15**†† 6.84±0.48††  6.86±0.50 9.81±0.38**‡‡ 7.40±0.63  11.19±0.87?  11.64±0.51?  10.7±0.53?  
% GJ on MF 3.23±0.54 19.3±1.60** 2.35±0.21  2.57±0.53 13±0.90**† 2.95±0.35  3.49±0.51 7.09±0.52**‡‡ 2.75±0.44  9.62±0.83? ?  8.12±0.56 8.95±0.63? ?
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Cx43 in ventricle vs. atrium, Cx40 in ventricle vs. AVN and atrial levels of Cx43 vs. Cx40 were compared using unpaired t-test. †P < 0.01 and ††P < 0.001 vs. Cx43 in ventricle at 
same time point. ‡P < 0.05 and ‡‡P < 0.0001 vs. Cx43 in atrium at same time point.  ? P < 0.05 and ? ? P < 0.0001 vs. Cx40 in atrium at same time point.  
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Table 3 - Gap junctions expressed by fibroblasts in fibroblast-rich areas at 
the interface between ventricle and AVN 
 
Data obtained at control and different post-infarction time points were compared using ANOVA. 
Gap junction density is expressed as area of connexin related fluorescence per fibroblast area (?m2??m-
2).  
Data are presented as mean ± S.E.M. *P < 0.05 and **P < 0.001 vs. control (statistically significant 
differences).  
 Cx43 Cx40 
 Control 
n=25 
8 weeks 
n=55 
32 weeks 
n=52 
Control 
n=43 
8 weeks 
n=46 
32 weeks 
n=68 
Area?10-2 ? m2?? m -2 7.11±0.96 3.12±0.21** 4.42±0.28** 0.85±0.18 2.60±0.46** 1.94±0.13* 
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Effect of Acidosis (simulation study) 
(Courtesy of Shin Inada and Mark Boyett, University of Manchester) 
Recently, this group developed action potential models for AN, N and NH cells of 
the rabbit atrioventricular (AV) node. From these models, they constructed a 1D 
string model. This model has atrial cells (AM), a slow pathway (SP) made up of N 
cells, a fast pathway made up of AN cells, and transitional NH cells. The model is 
composed of 500 elements (150 AM elements, 150 N elements, 150 AN elements 
and 50 NH elements). This represents the conduction pathway from the atrial 
muscle, through the AV node to the His bundle (Figure 1A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 – Effect of acidosis simulation study. (Courtesy of Dr Inada and Dr Boyett, 
University of Manchester) A - 1D string model. This model has atrial cells (AM), a slow 
pathway (SP) made up of N cells, a fast pathway made up of AN cells, and transitional 
NH cells. The model is composed of 500 elements (150 AM elements, 150 N elements, 
150 AN elements and 50 NH elements). This represents the conduction pathway from 
the atrial muscle, through the AV node to the His bundle. B - relationship between 
activation time (in ms) and cell number (distance from atrium). In this simulation, the 
conduction time from atrial muscle to the His bundle (AH interval) was 88 ms. C and D 
– effect of acidosis on activation sequence and refractory curve. 
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Action potential propagation in 1D model (normal conditions) are illustrated 
below. Figure 2 shows calculated action potentials and action potential 
propagation in normal conditions. In this simulation, the atrial cells (top of the 
figure) were stimulated. The action potential propagated from the atrial muscle 
to the His bundle. In this simulation A1A1 interval was 350 ms.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 - Calculated action potentials and action potential propagation in normal 
conditions. AM – atrial cells; N – AV nodal cells; NH – nodal-His cells.  
Ashley M Nisbet; 2008  Appendix 2; 172 
Figure 1B shows the relationship between activation time (in ms) and cell number 
(distance from atrium). In this simulation, the conduction time from atrial muscle to 
the His bundle (AH interval) was 88 ms. Figure 3 shows refractory curves. The  
simulation results (in red) are comparable to experimental data (in black).  
 
 
 
 
To simulate the effect of acidosis, they reduced the L-type Ca2+ current (ICa,L), rapid 
delayed K+ current (IK,r), Na+ current (INa) and cell-to-cell coupling (gj). When gCa,L was 
set to 66 %, gK,r was set to 58 %, gNa was set to 75 %, gj was set to 69 % in the atrial 
muscle and AN and NH regions, and gj was set to 21 % in the N region, action 
potential propagation was slowed and the effective refractory period (ERP) and 
functional refractory period (FRP) were prolonged. Note the decrease in INa and gj is 
based on reported changes in the literature. Acidosis has a greater effect on Cx45 
than Cx43; this is why we assumed a greater decrease in gj in N cells. The effect of 
acidosis on gj is mediated by the intracellular pH; they estimated changes in 
intracellular pH from the literature. Table 1 documents the changes in conduction 
time, ERP and FRP with acidosis both in published experimental work and in this 
simulation study.  
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Figure 3 – Refractory curves of experimental data (black) and simulation data (red).  
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Figure 4 - Calculated action potentials and action potential propagation in normal and acidosis 
conditions. Note the marked slowing of conduction at the slow pathway of the the AV node. AM – 
atrial cells; N – AV nodal cells; NH – nodal-His cells.  
 
In summary, the simulation results showed a prolongation of the effective refractory 
period and functional refractory period as well as increase in the AV node 
conduction time. These results are comparable to experimental results. 
Furthermore, the simulation results suggest a significantly greater delay in 
conduction in the slow pathway consistent with optical mapping data shown earlier 
in this thesis.  
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Table 1 – Acidosis simulation data (top section) compared with experimental data 
(bottom section). CT – conduction time. To simulate the effect of acidosis, they 
reduced the L-type Ca2+ current (ICa,L), rapid delayed K+ current (IK,r), Na+
current (INa) and cell-to-cell coupling (gj). When gCa,L was set to 66 %, gK,r was 
set to 58 %, gNa was set to 75 %, gj was set to 69 % in the atrial muscle and AN 
and NH regions, and gj was set to 21 % in the N region, action potential 
propagation was slowed and the effective refractory period (ERP) and functional 
refractory period (FRP) were prolonged. Note the decrease in INa and gj is based 
on reported changes in the literature. Acidosis has a greater effect on Cx45 than 
Cx43; this is why they assumed a greater decrease in gj in N cells. The effect of 
acidosis on gj is mediated by the intracellular pH; they estimated changes in 
intracellular pH from the literature.  
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